US4639328A - Thienothiophene derivatives - Google Patents

Thienothiophene derivatives Download PDF

Info

Publication number
US4639328A
US4639328A US06/674,891 US67489184A US4639328A US 4639328 A US4639328 A US 4639328A US 67489184 A US67489184 A US 67489184A US 4639328 A US4639328 A US 4639328A
Authority
US
United States
Prior art keywords
sup
thiophene
phe
thieno
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/674,891
Inventor
Joachim Krause
Michael Romer
Georg Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Assigned to MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG reassignment MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: KRAUSE, JOACHIM, ROMER, MICHAEL, WEBER, GEORG
Application granted granted Critical
Publication of US4639328A publication Critical patent/US4639328A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom

Definitions

  • This invention relates to new thienothiophenes.
  • R 1 and R 2 are each H or an alkyl group having 1-12 C atoms, in which, furthermore, one or two non-adjacent CH 2 groups can be replaced by O atoms, --CO-- or --CH ⁇ CH-- groups, in the latter case, the resultant R 1 and R 2 groups having 2-12 C-- and oxa atoms in total, or are each F, Cl, Br, CN, --COOR or --O--COR;
  • a 1 and A 2 are each 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl, pyridazine-3,6-diyl or the corresponding N-oxide, piperidine-1,4-diyl, 1,4-bicyclo[2.2.2]octylene or pyrimidine-2,5-d
  • Phe is a 1,4-phenylene group
  • Cy is a 1,4-cyclohexylene group
  • Dio is a 1,3-dioxane-2,5-diyl group
  • Bi is a bicyclo[2.2.2.]octylene group
  • Pip is a piperidine-1,4-diyl group and Pyr is a pyrimidine-2,5-diyl group
  • these groups, in particular the 1,4-phenylene group and/or the 1,4-cyclohexylene group can be unsubstituted or substituted by one or two F and/or Cl and/or Br atoms and/or CN groups and/or CH 3 groups.
  • the compounds of the formula I can be used, like similar compounds, as components of liquid crystalline dielectrics, in particular for displays which are based on the principle of the twisted cell, the guest-host effect, the effect of deformation of aligned phases or the dynamic scattering effect.
  • the compounds of the formula I are outstandingly suitable as components of liquid crystalline phases. They can be used, in particular, for preparing stable liquid crystaline phases having positive or negative dielectric anisotropy, broad nematic ranges, favorable elastic properties and comparatively low viscosity.
  • the provision of the compounds of the formula I furthermore substantially broadens the range of liquid crystalline substances which are suitable for the preparation of nematic mixtures, from various points of view with regard to application technology.
  • the compounds of the formula I have a wide range of use. Depending on the choice of substituents, these compounds can be used as basic materials which form the predominant component of liquid crystalline phases; however, it is also possible for basic liquid crystalline materials obtained from other classes of compounds to be added to the compounds of the formula I, for example in order to vary the dielectric and/or optical anisotropy of such a phase.
  • the compounds of the formula I are furthermore suitable intermediates for the preparation of other substances which can be used as components of a liquid crystalline phase.
  • the compounds of the formula I in the pure state are colorless and form liquid crystalline meso phases in a temperature range which is advantageous for electro-optical use. They are very stable chemically, thermally and to light.
  • the invention therefore also relates to the compounds of the formula I and to a process for their preparation, characterized in that a compound which contains one or more reducible groups and/or C--C bonds in place of H atoms, but otherwise corresponds to the formula I, is treated with a reducing agent, or, for the preparation of esters of the formula I (in which R 1 and/or R 2 are --O--COR or --COOR, and/or in which Z 1 and/or Z 2 are --CO--O-- or --O--CO--), an appropriate carboxylic acid, or one of its reactive derivatives, is reacted with an appropriate alcohol or with one of its reactive derivatives, or, for the preparation of dioxane derivatives of the formula I (in which A 1 and/or A 2 are 1,3-dioxane-2,5-diyl), an appropriate aldehyde is reacted with an appropriate diol, or, for the preparation of nitriles of the formula I (in which R 1 and/or R
  • the invention furthermore relates to the use of the compounds of the formula I as components of liquid crystalline phases.
  • the invention furthermore relates to liquid crystalline phases which contain at least one compound of the formula I, and liquid crystal display elements, in particular electro-optical display elements, which contain phases of this type.
  • R 1 , R 2 , R, A, A 1 , A 2 , Z 1 , Z 2 , m, n, Q 1 , Q 2 and Q 3 are as defined, unless expressly stated otherwise.
  • the compounds of the formula I accordingly comprise compounds of the part formulae Ia (with two rings), Ib and Ic (each with three rings) and Id (with four rings):
  • the preferred compounds of the part formula Ia comprise those of the part formulae Ie to Ij:
  • R 1 and R 2 which can be identical or different, are preferably alkyl, alkoxy (particularly when this radical is on a Phe group) or another oxaalkyl group.
  • a 1 and A 2 are preferably Cy, Phe or Pyr, or furthermore preferably Dio or Pip; preferably, the compound of the formula I contains no more than one of the radicals Dio, Pip, Bic and Pyr.
  • A is preferably an unsubstituted group of the formula 1 or 2.
  • Z 1 and Z 2 which can be identical or different, are preferably single bonds, --CO--O, --O--CO-- or --CH 2 CH 2 -- groups or, as a second preference, --CO--O-- or --O--CO-- groups.
  • n is preferably O.
  • Alkyl radicals R 1 and/or R 2 in which furthermore an ("alkoxy” or “oxaalkyl") or two ("alkoxyalkoxy” or “dioxaalkyl”) non-adjacent CH 2 groups can be replaced by O atoms, can be straight-chain or branched.
  • R 2 is an alkyl radical or an alkoxy radical having 3 to 7 C atoms.
  • preferred compounds of the formula I are those, wherein one of the radicals R 1 and R 2 is a straight chain alkyl group having 2 to 7 C atoms and the other is a straight-chain alkoxy group having 2 to 12 C atoms.
  • the alkyl groups or alkoxy groups are likewise preferably straight-chain and are, in particular, methyl, ethyl, propyl, butyl or pentyl, in particular methyl, propyl or pentyl.
  • Preferred compounds of the formulae I and Ia to Iz are those in which at least one of the radicals present has one of the preferred meanings given.
  • Particularly preferred relatively small groups of compounds are those of the formulae Iaa to Iat:
  • Preferred compounds of the formula I which contain a 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl and/or piperidine-1,4-diyl-group are those in which these groups are trans-substituted.
  • the part formula Iap embraces the 2-R 1 -5-(A-R 2 )-1,3-dioxanes and the 2-(A-R 2 )-5-R 1 -1,3-dioxanes
  • the part formula Iaq embraces the 1-R 1 -4-(A-R 2 )-piperidines and the 1-(A-R 2 )-4-R 1 -piperidines.
  • formula I embraces the racemates as well as the optical antipodes and mixtures of these.
  • the compounds of the formula I are prepared by methods which are known per se, as are described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der Organischen Chemie (Methods of Organic Chemistry), Georg-Thieme-Verlag, Stuttgart), the reaction conditions used being those which are conventionally used and suitable for the stated reactions. In this context, it is also possible to use variants which are known per se but have not been specifically stated here.
  • the starting materials can, if desired, also be formed in situ in a procedure in which they are not isolated from the reaction mixture but are immediately reacted further to give compounds of the formula I.
  • the compounds of the formula I can be prepared by reducing a compound which contains one or more reducible groups and/or C--C bonds in place of H atoms, but otherwise corresponds to the formula I.
  • Preferred reducible groups are carbonyl groups, in particular keto groups, and furthermore, for example, free or esterified hydroxyl groups or aromatically bonded halogen atoms.
  • Preferred starting materials for the reduction are of the formula I but can contain a cyclohexene ring or cyclohexanone ring in place of a cyclohexane ring, and/or a --CH ⁇ CH-- group instead of a --CH 2 CH 2 -- group, and/or a --CO-- group in place of a --CH 2 -- group, and/or an OH group which is free or has been functionally modified (for example in the form of its p-toluenesulfonate) in place of an H atom.
  • the reduction can be carried out by, for example, hydrogenation of appropriate sulfonates or halides with zinc and an acid (for example glacial acetic acid or hydrochloric acid), or with complex hydrides (for example with NaBH 4 , advantageously in a solvent, such as dimethyl sulfoxide, or with LiAlH 4 , advantageously in a solvent, such as diethyl ether, dioxane or tetrahydrofuran).
  • the reduction is preferably carried out at temperatures between about 0° C. and about 100°.
  • the sulfonates or halides are obtainable by methods known from the literature, for example from the corresponding alcohols, which in turn are obtainable by reduction of the corresponding ketones.
  • Compounds having reducible C--C bonds can be converted to dihalides by methods known from the literature, and the dihalides can then be dehalogenated by the stated methods.
  • Ketones can furthermore be reduced to the corresponding compounds of the formula I which contain alkyl groups and/or --CH 2 CH 2 -bridges by the methods due to Clemmensen (with zinc, amalgamated zinc or tin and hydrochloric acid, advantageously in aqueous alcoholic solution or in the heterogeneous phase with water/toluene at temperatures between about 80° and 120°) or Wolff-Kishner (with hydrazine, advantageously in the presence of an alkali, such as KOH or NaOH, in a high-boiling solvent, such as diethylene glycol or triethylene glycol, at temperatures between about 100° and 200°).
  • Clemmensen with zinc, amalgamated zinc or tin and hydrochloric acid, advantageously in aqueous alcoholic solution or in the heterogeneous phase with water/toluene at temperatures between about 80° and 120°
  • Wolff-Kishner with hydrazine, advantageously in the presence of an alkali, such as K
  • Esters of the formula I can furthermore be obtained by esterification of the corresponding carboxylic acids of the formulae R--COOH, R 1 --(A 1 ) m --COOH, R 1 --(A 1 ) m --Z 1 --A--COOH, R 2 --(A 2 ) n --COOH or R 2 --(A 2 --Z 2 ) n --A--COOH (or their reactive derivatives) with alcohols or phenols of the formulae R 1 --(A 1 ) m --Z 1 --A--(Z 2 --A 2 ) n --OH, R 2 --(A 2 --Z 2 ) n --A--Z 1 --(A 1 ) m --OH, R 2 --(A 2 --Z 2 ) n --A--Z 1 --(A 1 ) m --OH, R 2 --(A 2 --Z 2 ) n --A---OH, R 2 --(A 2 ) n --OH, R 1 --(A 2 ) n --OH,
  • Particularly suitable reactive derivatives of the stated carboxylic acids are the acid halides, especially the chlorides and bromides, and furthermore the anhydrides, including, for example, mixed anhydrides of the formulae R 1 --(A 1 ) m --CO--O--COCH 3 , R 1 --(A 1 ) m --Z 1 --A--CO--O--COCH 3 , R 2 --(A 2 ) n --CO--O--COCH 3 and R 2 --(A 2 --Z 2 ) n --A--CO--O--COCH 3 , azides or esters, in particular alkyl esters having 1-4 C atoms in the alkyl group.
  • Particularly suitable reactive derivatives of the stated alcohols or phenols are the corresponding metal alcoholates or phenolates of the formulae R 1 --(A 1 ) m --Z 1 --A--(Z 2 --A 2 ) n --OM, R 2 --(A 2 --Z 2 ) n --A--Z 1 --(A 1 ) m --OM, R 2 --(A 2 --Z 2 ) n --A--OM, R 2 --(A 2 ) n --OM, R 1 --(A 1 ) m --Z1--A--OM and R 1 --(A 1 ) m --OM, in which M is one equivalent of a metal, preferably of an alkali metal, such as Na or K.
  • the esterification is advantageously carried out in the presence of an inert solvent.
  • suitable solvents are ethers, such as diethyl ether, di-n-butyl ether, tetrahydrofuran, dioxane or anisole, ketones, such as acetone, butanone or cyclohexanone, amides, such as dimethylformamide or hexamethylphosphoric triamide, hydrocarbons, such as benzene, toluene or xylene, halogenohydrocarbons, such as carbon tetrachloride or tetrachloroethylene, and sulfoxides, such as dimethyl sulfoxide or sulfolane.
  • ethers such as diethyl ether, di-n-butyl ether, tetrahydrofuran, dioxane or anisole
  • ketones such as acetone, butanone or cyclohexanone
  • amides such as dimethyl
  • Water-immiscible solvents can at the same time advantageously be used for azeotropic distillation of the water formed during the esterification.
  • an excess of an organic base for example pyridine, quinoline or triethylamine, as a solvent for the esterification.
  • the esterification can also be carried out in the absence of a solvent, for example by simply heating the components in the presence of sodium acetate.
  • the reaction temperature is usually between -50° and +250°, preferably between -20° and +80°. At these temperatures, the esterification reactions are as a rule complete after 15 minutes to 48 hours.
  • a free carboxylic acid is reacted with a free alcohol or phenol as a rule in the presence of a strong acid, for example a mineral acid, such as hydrochloric acid or sulfuric acid.
  • a strong acid for example a mineral acid, such as hydrochloric acid or sulfuric acid.
  • a preferred reaction procedure comprises reacting an acid anhydride or, in particular, an acid chloride with an alcohol, preferably in a basic medium, particularly important bases being alkali metal hydroxides, such as sodium hydroxide or potassium hydroxide, alkali metal carbonates and bicarbonates, such as sodium carbonate, sodium bicarbonate, potassium carbonate or potassium bicarbonate, alkali metal acetates, such as sodium acetate or potassium acetate, alkaline earth metal hydroxides, such as calcium hydroxide, and organic bases, such as triethylamine, pyridine, lutidine, collidine or quinoline.
  • alkali metal hydroxides such as sodium hydroxide or potassium hydroxide
  • alkali metal carbonates and bicarbonates such as sodium carbonate, sodium bicarbonate, potassium carbonate or potassium bicarbonate
  • alkali metal acetates such as sodium acetate or potassium acetate
  • alkaline earth metal hydroxides such as calcium hydroxide
  • organic bases such as triethylamine
  • the alcohol or the phenol is first converted to the sodium or potassium alcoholate or phenolate, for example by treatment with ethanolic sodium hydroxide or potassium hydroxide solution, the product is isolated and, together with sodium bicarbonate or potassium carbonate, is suspended in acetone or diethyl ether, with stirring, and this suspension is treated with a solution of the acid chloride or of the anhydride in diethyl ether, acetone or dimethylformamide, advantageously at temperatures between about -25° and +20°.
  • Dioxane derivatives of the formula I are advantageously prepared by reacting an appropriate aldehyde, for example an aldehyde of the formula R 1 --(A 1 ) m-1 --CHO, R 1 --(A 1 ) m --Z 1 --A--Z 2 --CHO, O ⁇ CH--(A 1 ) m-1 --Z 1 --A--(Z 2 --A 2 ) n --R 2 or O ⁇ CH--R 2 (or one of its reactive derivatives) with an appropriate 1,3-diol, for example a diol of the formula (HOCH 2 ) 2 CH--(A 1 ) m-1 --Z 1 --A--(Z 2 --A 2 ) n --R 2 , (HOCH 2 ) 2 CH--R 2 , R 1 --(A 1 ) m-1 --CH(CH 2 OH) 2 or
  • Suitable reactive derivatives of the starting materials are primarily acetals, for example those of the formulae R 1 --(A 1 ) m-1 CH(OR 3 ) 2 , R 1 --(A 1 ) m --Z 1 --A--Z 2 --CH(OR 3 ) 2 , (R 3 O) 2 CH--(A 1 ) m-1 --Z 1 --A--(Z 2 --A 2 ) n --R 2 , (R 3 O) 2 --R 2 , R 4 --CH(OCH 2 ) 2 CH--(A 1 ) m-1 --Z 1 --A--(Z 2 --A 2 ) n --R 2 , R 4 --CH(OCH 2 ) 2 CH--R 2 , R 1 --(A 1 ) m-1 --CH(CH 2 O) 2 CH--R 4 or R 1 --(A 1 ) m --Z 1 -- A--Z 1 CH(CH 2 O) 2 --CHR 4 , in which R 3 is alkyl having 1-4 C
  • aldehydes and 1,3-diols and their reactive derivatives are known, and some of them can be prepared without difficulty from compounds known from the literature, using standard methods of organic chemistry.
  • the aldehydes are obtainable by oxidation of the corresponding alcohols or by reduction of corresponding carboxylic acids or their derivatives, or the diols are obtainable by reduction of the corresponding diesters.
  • Nitriles of the formula I (in which R 1 and/or R 2 are CN and/or A 1 and/or A 2 is substituted by at least one CN group) can be prepared by dehydrating appropriate acid amides, for example those which contain a CONH 2 group in place of the radical X.
  • the amides are obtainable, for example, from the corresponding esters or acid halides by reaction with ammonia.
  • Suitable agents which eliminate water are inorganic acid chlorides, such as SOCl 2 , PCl 3 , PCl 5 , POCl 3 , SO 2 Cl 2 and COCl 2 , as well as P 2 O 5 , P 2 S 5 , AlCl 3 (for example as a double compound with NaCl), aromatic sulfonic acids and sulfonyl halides.
  • the reaction can be carried out in the presence or absence of an inert solvent at temperatures between about 0° and 150°;
  • suitable solvents are bases, such as pyridine or triethylamine, aromatic hydrocarbons, such as benzene, toluene or xylene, and amides, such as dimethylformamide.
  • nitriles of the formula I can also be prepared by reacting appropriate acid halides, preferably the chlorides, with sulfamide, advantageously in an inert solvent, such as tetramethylene sulfone, at temperatures between about 80° and 150°, preferably at 120°. After the usual working-up procedure, the nitriles can be isolated directly.
  • Ethers of the formula I are obtainable by etherification from appropriate hydroxy compounds, preferably appropriate phenols, the hydroxy compound advantageously first being converted to an appropriate metal derivative, for example to the corresponding alkali metal alcoholate or alkali metal phenolate by treatment with NaH, NaNH 2 , NaOH, KOH, Na 2 CO 3 or K 2 CO 3 .
  • This product can then be reacted with the appropriate alkyl halide or sulfonate or dialkyl sulfate, advantageously in an inert solvent, such as acetone, 1,2-dimethoxyethane, dimethylformamide or dimethyl sulfoxide, or even in an excess of aqueous or aqueous alcoholic NaOH or KOH, at temperatures between about 20° and 100°.
  • an inert solvent such as acetone, 1,2-dimethoxyethane, dimethylformamide or dimethyl sulfoxide
  • Nitriles of the formula I can furthermore be prepared by reacting appropriate chlorine or bromine compounds of the formula I (in which R 1 and/or R 2 is Cl or Br and/or in which A 1 and/or A 2 is substituted by at least one Cl or Br atom), with a cyanide, advantageously with a metal cyanide, such as NaCN, KCN or Cu 2 (CN) 2 , for example in the presence of pyridine in an inert solvent, such as dimethylformamide or N-methylpyrrolidone, at temperatures between 20° and 200°.
  • a cyanide advantageously with a metal cyanide, such as NaCN, KCN or Cu 2 (CN) 2 , for example in the presence of pyridine in an inert solvent, such as dimethylformamide or N-methylpyrrolidone, at temperatures between 20° and 200°.
  • the liquid crystalline phases according to the invention comprise at least two liquid-crystal components, wherein at least one is a compound having the structure wing group-ring-(bridging element-ring).sub.(1-3) -wing group wherein the ring groups, the bridging elements and at least one ring are conventional structural elements in liquid crystal compounds, wherein one ring is of the formula ##STR5## and said at least one compound is present in an amount effective to improve the elastic properties of the phase.
  • These phases preferably comprise 2 to 15, in particular 3 to 12, components and preferably at least one compound of the formula I.
  • components are preferably chosen from the nematic or nematogenic substances, in particular the known substances, from the classes comprising the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl benzoates, cyclohexyl benzoates, phenyl cyclohexanecarboxylate, cyclohexyl cyclohexanecarboxylate, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-bis-cyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenylpyrimidines, cyclohexylpyrimidines, phenylpyridazines, cyclohexylpyridazines, phenyld
  • L and E are each a carbocyclic or heterocyclic ring system obtained from the group formed from 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline, G is
  • Y is halogen, preferably chlorine, or --CN
  • R' and R" are alkyl, alkoxy, alkanoyloxy or alkoxycarbonyloxy having up to 18, preferably up to 8, carbon atoms, or one of these radicals may furthermore be CN, NC, NO 2 , CF 3 , F, Cl or Br.
  • R' and R" differ from one another, one of these radicals generally being an alkyl or alkoxy group.
  • substituents envisaged are also commonly used. Many such substances, or mixtures thereof, are available commercially. All of these substances can be prepared by methods known from the literature.
  • the phases according to the invention contain about 0.1 to 99, preferably 10 to 90, % of one or more compounds of the formula I.
  • Other preferred phases according to the invention are those containing 0.1 to 70, in particular 0.5 to 60, % of one or more compounds of the formula I.
  • the phases according to the invention are prepared in a conventional manner.
  • the components are dissolved, one in the other, advantageously at elevated temperature.
  • liquid crystalline phases according to the invention can be modified so that they can be used in all types of liquid crystal display elements disclosed to date.
  • Additives of this type are known to those skilled in the art, and are described in detail in the literature.
  • conductive salts preferably ethyl-dimethyl-dodecyl-ammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf. for example I. Haller et al., Mol. Cryst. Liq. Cryst. volume 24, pages 249-258 (1973)), for improving the conductivity, dichroic dyes for producing colored guest-host systems, or substances for altering the dielectric anisotropy, the viscosity and/or the orientation of the nematic phases.
  • m.p. is the melting point and c.p. is the clear point of a liquid crystal substance.
  • “Usual working-up procedure” means the following: water is added, the mixture is extracted with methylene chloride, the phases are separated, the organic phase is dried and evaporated down, and the product is purified by crystallization and/or chromatography.
  • a mixture of 12 g of 5-n-pentyl-thieno[3,2-b]thiophene-2-carbamidine (obtainable by reacting the nitrile with hydrogen chloride/ethanol and subsequently with ammonia) and 11,4 g of n-pentyl-malonicdialdehyde tetraethylacetal is heated for 12 hours at -160° (bath temperature).
  • the crystals obtained after cooling are purified by chromatography and crystallization.
  • the acid is obtainable by reacting ethyl ester of (5-n-pentyl-3-formyl-2-thienylmercapto)acetic acid [obtainable by reacting 2-n-pentylthiophene with butyllithium, sulfur and ethyl ester of chloroacetic acid and followed by Vilsmeyer formylation of the obtained 5-n-pentyl-2-thienylmercapto-acetic ester] with sodium ethylate[ethanol] in 20 ml of toluene was added dropwise to a mixture of 2,25 g of 4-n-pentylphenol, 1,08 g of pyridine and 30 ml of toluene, the mixture is heated to the boil for 2 hours and allowed to cool, the pyridine hydrochloride is filtered off, and the mixture is worked up in the usual manner.
  • ethyl ester of (5-n-pentyl-3-formyl-2-thienylmercapto)acetic acid
  • liquid crystalline phases according to the invention which contain at least one compound of the formula I are given below:
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • An electro-optical display element containing this phase as a dielectric has a low threshold voltage V 10 of 1.15 V.
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • this dielectric has a melting point of -12°, a clear point of 71° and a viscosity of 18 cSt. In an electro-optical display element, this dielectric has good multiplex properties (1:32).
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of
  • a liquid crystalline phase consisting of

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Liquid Crystal Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Thienothiophene derivatives of the formula I
R.sup.1 --(A.sup.1).sub.m --Z.sup.1 --A--(Z.sup.2 --A.sup.2).sub.n
--R2 I
in which R1 and R2 are each H or an alkyl group having 1-12 C atoms, in which, furthermore, one or two non-adjacent CH2 groups can be replaced by O atoms, --CO-- or --CH═CH-- groups, or are each F, Cl, Br, CN, --COOR or --O--COR, A1 and A2 are each 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl, pyridazine-3,6-diyl or the corresponding N-oxide, piperidine-1,4-diyl, 1,4-bicyclo[2.2.2]octylene or pyrimidine-2,5-diyl groups which are unsubstituted or substituted by one or two F, Cl or Br atoms and/or CN groups and/or CH3 groups, A is a group of the formula 1 or 2 ##STR1## which is unsubstituted or substituted by one or two Cl and/or Br atoms, Z1 and Z2 are each --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O-- or a single bond, R is an alkyl group having 1-10 C atoms, m is 1 or 2 and n is 0 or 1, and where m is 2, the two groups A1 can be identical or different, can be used as components of liquid crystalline phases.

Description

This invention relates to new thienothiophenes.
SUMMARY OF THE INVENTION
It is an object of this invention to provide new compounds having valuable properties, e.g., liquid crystalline compounds.
It is another object of this invention to provide novel stable liquid crystalline or mesogenic compounds which are suitable as components of liquid crystalline phases.
Upon further study of the specification and appended claims, further objects and advantages of this invention will become apparent to those skilled in the art.
These objects have been achieved by providing novel thienothiophene derivatives of the formula I
R.sup.1 --(A.sup.1).sub.m --Z.sup.1 --A--(Z.sup.2 --A.sup.2).sub.n --R.sup.2                                                 I
in which R1 and R2 are each H or an alkyl group having 1-12 C atoms, in which, furthermore, one or two non-adjacent CH2 groups can be replaced by O atoms, --CO-- or --CH═CH-- groups, in the latter case, the resultant R1 and R2 groups having 2-12 C-- and oxa atoms in total, or are each F, Cl, Br, CN, --COOR or --O--COR; A1 and A2 are each 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl, pyridazine-3,6-diyl or the corresponding N-oxide, piperidine-1,4-diyl, 1,4-bicyclo[2.2.2]octylene or pyrimidine-2,5-diyl groups which are unsubstituted or substituted by one or two F, Cl or Br atoms and/or CN groups and/or CH3 groups; A is a group of the formula 1 or 2 ##STR2## which is unsubstituted or substituted by one or two Cl and/or Br atoms; Z1 and Z2 are each --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O-- or a single bond; R is an alkyl group having 1-10 C atoms; m is 1 or 2; and n is 0 or 1; and where m is 2, the two groups A1 can be identical or different.
For the sake of simplicity, in the text which follows Phe is a 1,4-phenylene group, Cy is a 1,4-cyclohexylene group, Dio is a 1,3-dioxane-2,5-diyl group, Bi is a bicyclo[2.2.2.]octylene group, Pip is a piperidine-1,4-diyl group and Pyr is a pyrimidine-2,5-diyl group, and these groups, in particular the 1,4-phenylene group and/or the 1,4-cyclohexylene group, can be unsubstituted or substituted by one or two F and/or Cl and/or Br atoms and/or CN groups and/or CH3 groups.
The compounds of the formula I can be used, like similar compounds, as components of liquid crystalline dielectrics, in particular for displays which are based on the principle of the twisted cell, the guest-host effect, the effect of deformation of aligned phases or the dynamic scattering effect.
It has been found that the compounds of the formula I are outstandingly suitable as components of liquid crystalline phases. They can be used, in particular, for preparing stable liquid crystaline phases having positive or negative dielectric anisotropy, broad nematic ranges, favorable elastic properties and comparatively low viscosity.
Very generally, the provision of the compounds of the formula I furthermore substantially broadens the range of liquid crystalline substances which are suitable for the preparation of nematic mixtures, from various points of view with regard to application technology.
DETAILED DISCUSSION
The compounds of the formula I have a wide range of use. Depending on the choice of substituents, these compounds can be used as basic materials which form the predominant component of liquid crystalline phases; however, it is also possible for basic liquid crystalline materials obtained from other classes of compounds to be added to the compounds of the formula I, for example in order to vary the dielectric and/or optical anisotropy of such a phase. The compounds of the formula I are furthermore suitable intermediates for the preparation of other substances which can be used as components of a liquid crystalline phase.
The compounds of the formula I in the pure state are colorless and form liquid crystalline meso phases in a temperature range which is advantageous for electro-optical use. They are very stable chemically, thermally and to light.
The invention therefore also relates to the compounds of the formula I and to a process for their preparation, characterized in that a compound which contains one or more reducible groups and/or C--C bonds in place of H atoms, but otherwise corresponds to the formula I, is treated with a reducing agent, or, for the preparation of esters of the formula I (in which R1 and/or R2 are --O--COR or --COOR, and/or in which Z1 and/or Z2 are --CO--O-- or --O--CO--), an appropriate carboxylic acid, or one of its reactive derivatives, is reacted with an appropriate alcohol or with one of its reactive derivatives, or, for the preparation of dioxane derivatives of the formula I (in which A1 and/or A2 are 1,3-dioxane-2,5-diyl), an appropriate aldehyde is reacted with an appropriate diol, or, for the preparation of nitriles of the formula I (in which R1 and/or R2 are CN), an appropriate carboxamide is dehydrated or an appropriate carboxylic acid halide is reacted with sulfamide, or a thiophene derivative of the formula II ##STR3## in which one of the radicals Q1 and Q2 is --CHO, and the other is --SCH2 --Q3, and Q3 is R1 --(A1)m --Z1 -- or R2 --(A2 --Z2)n --, is condensed, or, for the preparation of ethers of the formula I (in which R1 and R2 are each alkyl groups, or R1 or R2 is an alkyl group, in which one or two CH2 groups are replaced by O atoms, and/or Z1 and Z2 are each --OCH2 -- or --CH2 O-- groups or Z1 or Z2 is a --OCH2 -- or --CH2 O-- group), an appropriate hydroxy compound is etherified, and/or, if desired, a chlorine or bromine compound of the formula I (in which R1 and/or R2 are Cl or Br) is reacted with a cyanide.
The invention furthermore relates to the use of the compounds of the formula I as components of liquid crystalline phases.
The invention furthermore relates to liquid crystalline phases which contain at least one compound of the formula I, and liquid crystal display elements, in particular electro-optical display elements, which contain phases of this type.
Above and below, R1, R2, R, A, A1, A2, Z1, Z2, m, n, Q1, Q2 and Q3 are as defined, unless expressly stated otherwise.
The compounds of the formula I accordingly comprise compounds of the part formulae Ia (with two rings), Ib and Ic (each with three rings) and Id (with four rings):
R.sup.1 --A.sup.1 --Z.sup.1 --A--R.sup.2                   Ia
R.sup.1 --A.sup.1 --Z.sup.1 --A--Z.sup.2 --A.sup.2 --R.sup.2 Ib
R.sup.1 --(A.sup.1).sub.2 --Z.sup.1 --A--R.sup.2           Ic
R.sup.1 --(A.sup.1).sub.2 --Z.sup.1 --A--Z.sup.2 --A.sup.2 --R.sup.2 Id.
The preferred compounds of the part formula Ia comprise those of the part formulae Ie to Ij:
R.sup.1 --Phe--Z.sup.1 --A--R.sup.2                        Ie
R.sup.1 --Cy--Z.sup.1 --A--R.sup.2                         If
R.sup.1 --Dio--Z.sup.1 --A--R.sup.2                        Ig
R.sup.1 --Pip--Z.sup.1 --A--R.sup.2                        Ih
R.sup.1 --Bic--Z.sup.1 --A--R.sup.2                        Ii
R.sup.1 --Pyr--Z.sup.1 --A--R.sup.2                        Ij
Particularly preferred compounds among these are those of the formulae Ie, If and Ig.
Among the compounds of the part formulae Ib, Ic and Id, those of the part formulae Ik to Iz are particularly preferred:
R.sup.1 --Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2         Ik
R.sup.1 --Dio--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2          Il
R.sup.1 --Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2          Im
R.sup.1 --Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2           In
R.sup.1 --Phe--Phe--Z.sup.1 --A--R.sup.2                   Io
R.sup.1 --Phe--Cy--Z.sup.1 --A--R.sup.2                    Ip
R.sup.1 --Cy--Phe--Z.sup.1 --A--R.sup.2                    Iq
R.sup.1 --Cy--Cy--Z.sup.1 --A--R.sup.2                     Ir
R.sup.1 --Phe--Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2    Is
R.sup.1 --Phe--Phe--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2     It
R.sup.1 --Phe--Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2     Iu
R.sup.1 --Phe--Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2      Iv
R.sup.1 --Cy--Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2     Iw
R.sup.1 --Cy--Phe--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2      Ix
R.sup.1 --Cy--Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2      Iy
R.sup.1 --Cy--Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2       Iz
In the compounds of the formulae above and below, R1 and R2, which can be identical or different, are preferably alkyl, alkoxy (particularly when this radical is on a Phe group) or another oxaalkyl group.
Other preferred compounds of the formula I are those in which one of the radicals R1 and R2 is H, halogen, in particular F, or CN.
A1 and A2 are preferably Cy, Phe or Pyr, or furthermore preferably Dio or Pip; preferably, the compound of the formula I contains no more than one of the radicals Dio, Pip, Bic and Pyr.
Other preferred compounds of the formula I are those which contain at least one cycloaliphatic ring (Cy, Dio, Bi or Pip).
A is preferably an unsubstituted group of the formula 1 or 2.
Z1 and Z2, which can be identical or different, are preferably single bonds, --CO--O, --O--CO-- or --CH2 CH2 -- groups or, as a second preference, --CO--O-- or --O--CO-- groups. Particularly preferred are compounds according to the invention wherein one of the groups Z1 and Z2 is a single bond and the other is a --O--CO--, --CO--O-- or --CH2 CH2 -- group.
m is preferably 1 or 2, in particular 1, and n is preferably O.
Alkyl radicals R1 and/or R2, in which furthermore an ("alkoxy" or "oxaalkyl") or two ("alkoxyalkoxy" or "dioxaalkyl") non-adjacent CH2 groups can be replaced by O atoms, can be straight-chain or branched. They are preferably straight-chain and have 2, 3, 4, 5, 6 or 7 C atoms, and accordingly are preferably ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, 2-oxapropyl (=methoxymethyl), 2- (=ethoxymethyl) or 3-oxabutyl (=2-methoxyethyl), 2-, 3- or 4-oxapentyl, 2-, 3-, 4- or 5-oxahexyl, 2-, 3-, 4-, 5- or 6-oxaheptyl, or methyl, octyl, nonyl, decyl, undecyl, dodecyl, methoxy; octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, 2-, 3-, 4-, 5-, 6- or 7-oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl, 2-, 3-, 4 -, 5-, 6-, 7-, 8- or 9-oxadecyl, 1,3-dioxabutyl (=methoxymethoxy), 1,3-, 1,4- or 2,4-dioxapentyl, 1,3-, 1,4-, 1,5-, 2,4-, 2,5- or 3,5-dioxahexyl, or 1,3-, 1,4-, 1,5-, 1,6-, 2,4-, 2,5-, 2,6-, 3,5-, 3,6- or 4,6-dioxaheptyl.
Other preferred compounds of the formula I are those in which R2 is an alkyl radical or an alkoxy radical having 3 to 7 C atoms. Furthermore preferred compounds of the formula I are those, wherein one of the radicals R1 and R2 is a straight chain alkyl group having 2 to 7 C atoms and the other is a straight-chain alkoxy group having 2 to 12 C atoms.
Compounds of the formulae I and Ia to Iz which have branched wing groups R1 or R2 can sometimes be important because of higher solubility in the conventional liquid crystalline base materials, but are particularly important as chiral dopants if they possess optical activity. Branched groups of this type as a rule contain no more than one chain branching. Preferred branched radicals R1 and R2 are isopropyl, 2-butyl (=1-methylpropyl), isobutyl (=2-methylpropyl), 2-methylbutyl, isopentyl (=3-methylbutyl), 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl, 2-propylpentyl, isopropoxy, 2-methylpropoxy, 2-methylbutoxy, 3-methylbutoxy, 2-methylpentyloxy, 3-methylpentyloxy, 2-ethylhexyloxy, 1-methylhexyloxy, 1-methylheptyloxy, 2-oxa-3-methylbutyl and 3-oxa-4-methylpentyl.
In the radicals R, the alkyl groups or alkoxy groups are likewise preferably straight-chain and are, in particular, methyl, ethyl, propyl, butyl or pentyl, in particular methyl, propyl or pentyl.
Preferred compounds of the formulae I and Ia to Iz are those in which at least one of the radicals present has one of the preferred meanings given. Particularly preferred relatively small groups of compounds are those of the formulae Iaa to Iat:
R.sup.1 --A.sup.1 --Z.sup.1 --A--R.sup.2                   Iaa
R.sup.1 --Phe--Z.sup.1 --A--R.sup.2                        Iab
R.sup.1 --Phe--A--R.sup.2                                  Iac
R.sup.1 --Phe--CO--O--A--R.sup.2                           Iad
R.sup.1 --Phe--O--CO--A--R.sup.2                           Iae
R.sup.1 --Phe--CH.sub.2 CH.sub.2 --A--R.sup.2              Iaf
R.sup.1 --Phe--O--CH.sub.2 --A--R.sup.2                    Iag
R.sup.1 --Phe--CH.sub.2 --O--A--R.sup.2                    Iah
R.sup.1 --Cy--Z.sup.1 --A--R.sup.2                         Iai
R.sup.1 --Cy--A--R.sup.2                                   Iaj
R.sup.1 --Cy--CO--O--A--R.sup.2                            Iak
R.sup.1 --Cy--O--CO--A--R.sup.2                            Ial
R.sup.1 --Cy--CH.sub.2 CH.sub.2 --A--R.sup.2               Iam
R.sup.1 --Cy--O--CH.sub.2 --A--R.sup.2                     Ian
R.sup.1 --Cy--CH.sub.2 --O--A--R.sup.2                     Iao
R.sup.1 --Dio--A--R.sup.2                                  Iap
R.sup.1 --Pip--A--R.sup.2                                  Iaq
R.sup.1 --Bic--A--R.sup.2                                  Iar
R.sup.1 --Pyr--A--R.sup.2                                  Ias
R.sup.1 --Phe--Phe--A--R.sup.2                             Iat.
Preferred compounds of the formula I which contain a 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl and/or piperidine-1,4-diyl-group are those in which these groups are trans-substituted.
Those compounds of the abovementioned formulae which contain one or more of the groups Dio, Pip and/or Pyr include in each case the two possible 2,5- and 1,4-positional isomers. Thus, for example, the part formula Iap embraces the 2-R1 -5-(A-R2)-1,3-dioxanes and the 2-(A-R2)-5-R1 -1,3-dioxanes, while the part formula Iaq embraces the 1-R1 -4-(A-R2)-piperidines and the 1-(A-R2)-4-R1 -piperidines.
Where compounds of the formula I have branched wing groups R1 and/or R2, formula I embraces the racemates as well as the optical antipodes and mixtures of these.
The foregoing discussion was directed in large part to the preferred rings Phe, Cy, Dio, Pip, Bi and Pyr but applies fully analogously to the other ring embodiments of A1 and A2. Similarly, it applies fully analogously to the substituted versions of the A, A1 and/or A2 rings. It also applies fully analogously to the alkyl R1 and/or R2 groups containing --CO-- and/or --CH═CH-- groups.
The compounds of the formula I are prepared by methods which are known per se, as are described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der Organischen Chemie (Methods of Organic Chemistry), Georg-Thieme-Verlag, Stuttgart), the reaction conditions used being those which are conventionally used and suitable for the stated reactions. In this context, it is also possible to use variants which are known per se but have not been specifically stated here.
In the synthesis of the starting materials, in principle all methods can be used which, on the one hand, are conventionally used for the compounds of the formula I which carry other groups in place of the group A and, on the other hand, are conventionally used for the thiophene derivatives of the formula II which carry other radicals in place of the radicals Q1, Q2 and/or Q3. The skilled worker can derive the required synthesis variants by routine methods.
The starting materials can, if desired, also be formed in situ in a procedure in which they are not isolated from the reaction mixture but are immediately reacted further to give compounds of the formula I.
For example, the compounds of the formula I can be prepared by reducing a compound which contains one or more reducible groups and/or C--C bonds in place of H atoms, but otherwise corresponds to the formula I.
Preferred reducible groups are carbonyl groups, in particular keto groups, and furthermore, for example, free or esterified hydroxyl groups or aromatically bonded halogen atoms. Preferred starting materials for the reduction are of the formula I but can contain a cyclohexene ring or cyclohexanone ring in place of a cyclohexane ring, and/or a --CH═CH-- group instead of a --CH2 CH2 -- group, and/or a --CO-- group in place of a --CH2 -- group, and/or an OH group which is free or has been functionally modified (for example in the form of its p-toluenesulfonate) in place of an H atom.
The reduction can be carried out by, for example, hydrogenation of appropriate sulfonates or halides with zinc and an acid (for example glacial acetic acid or hydrochloric acid), or with complex hydrides (for example with NaBH4, advantageously in a solvent, such as dimethyl sulfoxide, or with LiAlH4, advantageously in a solvent, such as diethyl ether, dioxane or tetrahydrofuran). The reduction is preferably carried out at temperatures between about 0° C. and about 100°.
The sulfonates or halides are obtainable by methods known from the literature, for example from the corresponding alcohols, which in turn are obtainable by reduction of the corresponding ketones. Compounds having reducible C--C bonds can be converted to dihalides by methods known from the literature, and the dihalides can then be dehalogenated by the stated methods.
Ketones can furthermore be reduced to the corresponding compounds of the formula I which contain alkyl groups and/or --CH2 CH2 -bridges by the methods due to Clemmensen (with zinc, amalgamated zinc or tin and hydrochloric acid, advantageously in aqueous alcoholic solution or in the heterogeneous phase with water/toluene at temperatures between about 80° and 120°) or Wolff-Kishner (with hydrazine, advantageously in the presence of an alkali, such as KOH or NaOH, in a high-boiling solvent, such as diethylene glycol or triethylene glycol, at temperatures between about 100° and 200°).
Esters of the formula I (R1 and/or R2 =--O--COR or Z1 and/or Z2 =--CO--O-- or --O--CO--) can furthermore be obtained by esterification of the corresponding carboxylic acids of the formulae R--COOH, R1 --(A1)m --COOH, R1 --(A1)m --Z1 --A--COOH, R2 --(A2)n --COOH or R2 --(A2 --Z2)n --A--COOH (or their reactive derivatives) with alcohols or phenols of the formulae R1 --(A1)m --Z1 --A--(Z2 --A2)n --OH, R2 --(A2 --Z2)n --A--Z1 --(A1)m --OH, R2 --(A2 --Z2)n --A--OH, R2 --(A2)n --OH, R1 --(A1)m --Z1 --A--OH or R1 --(A1)m --OH (or their reactive derivatives).
Particularly suitable reactive derivatives of the stated carboxylic acids are the acid halides, especially the chlorides and bromides, and furthermore the anhydrides, including, for example, mixed anhydrides of the formulae R1 --(A1)m --CO--O--COCH3, R1 --(A1)m --Z1 --A--CO--O--COCH3, R2 --(A2)n --CO--O--COCH3 and R2 --(A2 --Z2)n --A--CO--O--COCH3, azides or esters, in particular alkyl esters having 1-4 C atoms in the alkyl group.
Particularly suitable reactive derivatives of the stated alcohols or phenols are the corresponding metal alcoholates or phenolates of the formulae R1 --(A1)m --Z1 --A--(Z2 --A2)n --OM, R2 --(A2 --Z2)n --A--Z1 --(A1)m --OM, R2 --(A2 --Z2)n --A--OM, R2 --(A2)n --OM, R1 --(A1)m --Z1--A--OM and R1 --(A1)m --OM, in which M is one equivalent of a metal, preferably of an alkali metal, such as Na or K.
The esterification is advantageously carried out in the presence of an inert solvent. Particularly suitable solvents are ethers, such as diethyl ether, di-n-butyl ether, tetrahydrofuran, dioxane or anisole, ketones, such as acetone, butanone or cyclohexanone, amides, such as dimethylformamide or hexamethylphosphoric triamide, hydrocarbons, such as benzene, toluene or xylene, halogenohydrocarbons, such as carbon tetrachloride or tetrachloroethylene, and sulfoxides, such as dimethyl sulfoxide or sulfolane. Water-immiscible solvents can at the same time advantageously be used for azeotropic distillation of the water formed during the esterification. Occasionally, it is also possible to use an excess of an organic base, for example pyridine, quinoline or triethylamine, as a solvent for the esterification. The esterification can also be carried out in the absence of a solvent, for example by simply heating the components in the presence of sodium acetate. The reaction temperature is usually between -50° and +250°, preferably between -20° and +80°. At these temperatures, the esterification reactions are as a rule complete after 15 minutes to 48 hours.
The specific reaction conditions for the esterification depend substantially on the nature of the starting materials used. Thus, a free carboxylic acid is reacted with a free alcohol or phenol as a rule in the presence of a strong acid, for example a mineral acid, such as hydrochloric acid or sulfuric acid. A preferred reaction procedure comprises reacting an acid anhydride or, in particular, an acid chloride with an alcohol, preferably in a basic medium, particularly important bases being alkali metal hydroxides, such as sodium hydroxide or potassium hydroxide, alkali metal carbonates and bicarbonates, such as sodium carbonate, sodium bicarbonate, potassium carbonate or potassium bicarbonate, alkali metal acetates, such as sodium acetate or potassium acetate, alkaline earth metal hydroxides, such as calcium hydroxide, and organic bases, such as triethylamine, pyridine, lutidine, collidine or quinoline. In another preferred embodiment of the esterification, the alcohol or the phenol is first converted to the sodium or potassium alcoholate or phenolate, for example by treatment with ethanolic sodium hydroxide or potassium hydroxide solution, the product is isolated and, together with sodium bicarbonate or potassium carbonate, is suspended in acetone or diethyl ether, with stirring, and this suspension is treated with a solution of the acid chloride or of the anhydride in diethyl ether, acetone or dimethylformamide, advantageously at temperatures between about -25° and +20°.
Dioxane derivatives of the formula I (in which one of the groups A1 and/or A2 is a 1,3-dioxane-2,5-diyl group) are advantageously prepared by reacting an appropriate aldehyde, for example an aldehyde of the formula R1 --(A1)m-1 --CHO, R1 --(A1)m --Z1 --A--Z2 --CHO, O═CH--(A1)m-1 --Z1 --A--(Z2 --A2)n --R2 or O═CH--R2 (or one of its reactive derivatives) with an appropriate 1,3-diol, for example a diol of the formula (HOCH2)2 CH--(A1)m-1 --Z1 --A--(Z2 --A2)n --R2, (HOCH2)2 CH--R2, R1 --(A1)m-1 --CH(CH2 OH)2 or R1 --(A1)m --Z1 --A--Z2 CH(CH2 OH)2 (or one of its reactive derivatives), preferably in the presence of an inert solvent, such as benzene or toluene, and/or of a catalyst, for example a strong acid, such as sulfuric acid, benzenesulfonic acid or p-toluenesulfonic acid, at temperatures between about 20° and about 150°, preferably between 80° and 120°. Suitable reactive derivatives of the starting materials are primarily acetals, for example those of the formulae R1 --(A1)m-1 CH(OR3)2, R1 --(A1)m --Z1 --A--Z2 --CH(OR3)2, (R3 O)2 CH--(A1)m-1 --Z1 --A--(Z2 --A2)n --R2, (R3 O)2 --R2, R4 --CH(OCH2)2 CH--(A1)m-1 --Z1 --A--(Z2 --A2)n --R2, R4 --CH(OCH2)2 CH--R2, R1 --(A1)m-1 --CH(CH2 O)2 CH--R4 or R1 --(A1)m --Z1 -- A--Z1 CH(CH2 O)2 --CHR4, in which R3 is alkyl having 1-4 C atoms, two radicals R3 together may furthermore be alkylene having 2 or 3 C atoms, and R4 is H, alkyl having 1-4 C atoms or phenyl.
Some of the stated aldehydes and 1,3-diols and their reactive derivatives are known, and some of them can be prepared without difficulty from compounds known from the literature, using standard methods of organic chemistry. For example, the aldehydes are obtainable by oxidation of the corresponding alcohols or by reduction of corresponding carboxylic acids or their derivatives, or the diols are obtainable by reduction of the corresponding diesters.
Nitriles of the formula I (in which R1 and/or R2 are CN and/or A1 and/or A2 is substituted by at least one CN group) can be prepared by dehydrating appropriate acid amides, for example those which contain a CONH2 group in place of the radical X. The amides are obtainable, for example, from the corresponding esters or acid halides by reaction with ammonia. Examples of suitable agents which eliminate water are inorganic acid chlorides, such as SOCl2, PCl3, PCl5, POCl3, SO2 Cl2 and COCl2, as well as P2 O5, P2 S5, AlCl3 (for example as a double compound with NaCl), aromatic sulfonic acids and sulfonyl halides. The reaction can be carried out in the presence or absence of an inert solvent at temperatures between about 0° and 150°; examples of suitable solvents are bases, such as pyridine or triethylamine, aromatic hydrocarbons, such as benzene, toluene or xylene, and amides, such as dimethylformamide.
The abovementioned nitriles of the formula I can also be prepared by reacting appropriate acid halides, preferably the chlorides, with sulfamide, advantageously in an inert solvent, such as tetramethylene sulfone, at temperatures between about 80° and 150°, preferably at 120°. After the usual working-up procedure, the nitriles can be isolated directly.
Compounds of the formula I are furthermore obtainable by condensing a thiophene derivative of the formula II ##STR4## in which one of the radicals Q1 and Q2 is --CHO and the other is --SCH2 --Q3, and Q3 is R1 --(A1)m --Z1 -- or R2 --(A2 --Z2)n --.
The preparation of the compounds of the formula II and their condensation can be carried out by methods which are known per se, as described in the literature [for example V. P. Litvinov and Ya. L. Gold'farb, Izv. Akad. Nauk. SSSR, Ser. Khim., 2183 (1963)], the reaction conditions employed being those which are conventionally used and suitable for the stated reactions. In this context, it is also possible to use variants which are known per se but are not specifically mentioned here.
Ethers of the formula I (in which R1 and/or R2 are alkyl groups, in which one or two CH2 groups are replaced by O atoms, and/or in which Z1 and/or Z2 are --OCH2 -- or --CH2 O-- groups) are obtainable by etherification from appropriate hydroxy compounds, preferably appropriate phenols, the hydroxy compound advantageously first being converted to an appropriate metal derivative, for example to the corresponding alkali metal alcoholate or alkali metal phenolate by treatment with NaH, NaNH2, NaOH, KOH, Na2 CO3 or K2 CO3. This product can then be reacted with the appropriate alkyl halide or sulfonate or dialkyl sulfate, advantageously in an inert solvent, such as acetone, 1,2-dimethoxyethane, dimethylformamide or dimethyl sulfoxide, or even in an excess of aqueous or aqueous alcoholic NaOH or KOH, at temperatures between about 20° and 100°.
Nitriles of the formula I (in which R1 and/or R2 are CN and/or in which A1 and/or A2 is substituted by at least one CN group) can furthermore be prepared by reacting appropriate chlorine or bromine compounds of the formula I (in which R1 and/or R2 is Cl or Br and/or in which A1 and/or A2 is substituted by at least one Cl or Br atom), with a cyanide, advantageously with a metal cyanide, such as NaCN, KCN or Cu2 (CN)2, for example in the presence of pyridine in an inert solvent, such as dimethylformamide or N-methylpyrrolidone, at temperatures between 20° and 200°.
The liquid crystalline phases according to the invention comprise at least two liquid-crystal components, wherein at least one is a compound having the structure wing group-ring-(bridging element-ring).sub.(1-3) -wing group wherein the ring groups, the bridging elements and at least one ring are conventional structural elements in liquid crystal compounds, wherein one ring is of the formula ##STR5## and said at least one compound is present in an amount effective to improve the elastic properties of the phase. These phases preferably comprise 2 to 15, in particular 3 to 12, components and preferably at least one compound of the formula I.
In other components are preferably chosen from the nematic or nematogenic substances, in particular the known substances, from the classes comprising the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl benzoates, cyclohexyl benzoates, phenyl cyclohexanecarboxylate, cyclohexyl cyclohexanecarboxylate, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-bis-cyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenylpyrimidines, cyclohexylpyrimidines, phenylpyridazines, cyclohexylpyridazines, phenyldioxanes, cyclohexyldioxanes, phenyldithianes, cyclohexyldithianes, stilbenes which may or may not be halogenated, benzyl phenyl ether, tolanes and substituted cinnamic acids.
The most important compounds which can be used as components of such liquid crystalline phases can be characterised by the formula VI
R'--L--G--E--R"                                            VI
in which L and E are each a carbocyclic or heterocyclic ring system obtained from the group formed from 1,4-disubstituted benzene and cyclohexane rings, 4,4'-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline, G is
______________________________________                                    
G        --CH═CH-- --N(O)═N--                                     
         --CH═CY-- --CH═N(O)--                                    
         --C.tbd.C--   --CH.sub.2 --CH.sub.2 --                           
         --CO--O--     --CH.sub.2 --O--                                   
         --CO--S--     --CH.sub.2 --S--                                   
         --CH═N--  --COO--Phe--COO--                                  
______________________________________
or a C--C single bond, Y is halogen, preferably chlorine, or --CN, and R' and R" are alkyl, alkoxy, alkanoyloxy or alkoxycarbonyloxy having up to 18, preferably up to 8, carbon atoms, or one of these radicals may furthermore be CN, NC, NO2, CF3, F, Cl or Br.
In most of these compounds, R' and R" differ from one another, one of these radicals generally being an alkyl or alkoxy group. However, other variants of the substituents envisaged are also commonly used. Many such substances, or mixtures thereof, are available commercially. All of these substances can be prepared by methods known from the literature.
The phases according to the invention contain about 0.1 to 99, preferably 10 to 90, % of one or more compounds of the formula I. Other preferred phases according to the invention are those containing 0.1 to 70, in particular 0.5 to 60, % of one or more compounds of the formula I.
The phases according to the invention are prepared in a conventional manner. As a rule, the components are dissolved, one in the other, advantageously at elevated temperature.
By means of suitable additives, the liquid crystalline phases according to the invention can be modified so that they can be used in all types of liquid crystal display elements disclosed to date.
Additives of this type are known to those skilled in the art, and are described in detail in the literature. For example, it is possible to add conductive salts, preferably ethyl-dimethyl-dodecyl-ammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf. for example I. Haller et al., Mol. Cryst. Liq. Cryst. volume 24, pages 249-258 (1973)), for improving the conductivity, dichroic dyes for producing colored guest-host systems, or substances for altering the dielectric anisotropy, the viscosity and/or the orientation of the nematic phases. Substances of this type are described in, for example, German Offenlegungsschriften Nos. 2,209,127, 2,240,864, 2,321,632, 2,338,281, 2,450,088, 2,637,430, 2,853,728 and 2,902,177.
The chemical reactions described above are generally disclosed in terms of their broadest application to the preparation of the compounds of this invention. Occasionally, the reactions may not be applicable as described to each compound included within the disclosed scope. The compounds for which this occurs will be readily recognized by those skilled in the art. In all such cases, either the reactions can be successfully performed by conventional modifications known to those skilled in the art, e.g., by appropriate protection of interfering groups, by changing to alternative conventional reagents, by routine modification of reaction conditions, etc., or other reactions disclosed herein or otherwise conventional, will be applicable to the preparation of the corresponding compounds of this invention. In all preparative methods, all starting materials are known or readily preparable from known starting materials.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever. In the following examples, all temperatures are set forth uncorrected in degrees Celsius; unless otherwise indicated, all parts and percentages are by weight.
In the examples, m.p. is the melting point and c.p. is the clear point of a liquid crystal substance.
"Usual working-up procedure" means the following: water is added, the mixture is extracted with methylene chloride, the phases are separated, the organic phase is dried and evaporated down, and the product is purified by crystallization and/or chromatography.
EXAMPLE 1
3.5 g of 5-n-pentyl-thieno[3,2-b]thiophene-2-carboxylic acid chloride [obtainable by reacting 5-n-pentylthieno[3,2-b]thiophene-5-carboxylic acid (m.p. 156°, c.p. 196°) with thionyl chloride] in 20 ml of toluene are added dropwise to a mixture of 2.25 g of 4-n-pentylphenol, 1.08 g of pyridine and 30 ml of toluene, the mixture is heated to the boil for 2 hours and allowed to cool, the pyridine hydrochloride is filtered off, and the mixture is worked up in the usual manner. 4-n-Pentylphenyl 5-n-pentyl-thieno[3,2-b]thiophene-2-carboxylate of melting point 58° and clear point 93° is obtained.
The following compounds are prepared analogously:
4-ethylphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propylphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-phenyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-ethylphenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propylphenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-pentylphenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-ethylphenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propylphenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-pentylphenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-ethylphenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propylphenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-pentylphenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-ethylphenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propylphenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-pentylphenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-butyl-thieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate, m.p. 98°, c.p. 137°,
4-cyanophenyl 5-hexyl-thieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-heptyl-thieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-nonyl-thieno[3,2-b]thiophene-2-carboxylate,
4-fluorophenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-chlorophenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-bromophenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-methoxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-ethoxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-propoxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-butoxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-pentyloxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-heptyloxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-nonyloxyphenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4'-propylbiphenylyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4'-cyanobiphenylyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
2'-fluoro-4'-ethylbiphenylyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
2-methyl-4'-propylbiphenylyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-(4-propylcyclohexyl)-phenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
4-(1-cyano-4-propylcyclohexyl)-phenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate and
4-(5-propyl-1,3-dioxan-2-yl)-phenyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate.
trans-4-ethylcyclohexyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-propylcyclohexyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate, M.p. 45°, c.p. 93°
trans-4-butylcyclohexyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-pentylcyclohexyl 5-pentyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-heptylcyclohexyl 5-pentyl-thieno[3,2-b]-thiophene-2-carboxylate,
trans-4-ethylcyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-propylcyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-butylcyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-pentylcyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-heptylcyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-ethoxycyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans-4-butoxycyclohexyl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate,
trans,trans-4-ethylbicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-propylbicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-butylbicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-pentylbicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-heptylbicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-ethoxybicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-butoxybicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
trans,trans-4-propionyloxybicyclohex-4'-yl 5-propyl-thieno[3,2-b]thiophene-2-carboxylate
EXAMPLE 2
5.75 g of 2-[2-(trans-5-n-pentylcyclohexyl)-acetyl]-5-n-pentylthieno[3,2-b]thiophene [obtainable by reacting 5-n-pentylthieno[3,2-b]thiophene-2-carbonitrile (obtained from the acid chloride by reaction with ammonia followed by dehydration of the amide with thionyl chloride) with a Grignard solution prepared from trans-4-bromomethyl-n-pentylcyclohexane] are boiled with 2.5 g of 85% hydrazine hydrate, 3.2 g of potassium hydroxide and 15 ml of triethylene glycol for 2 hours, and then heated in an apparatus possessing a descending condenser until the internal temperature reaches 195° C., and kept at this temperature for 4 hours. Cooling, dilution with water and the usual working-up procedure give 4.1 g of 1-trans-4-pentylcyclohexyl-2-[pentylthieno[3,2-b]thien-2-yl]-ethane.
The following compounds are prepared analogously:
1-trans-4-methylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-nonylcyclohexyl-2-[5-pentylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-nonylcyclohexyl-2-[5-propylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-nonylcyclohexyl-2-[5-heptylthieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-(p-propylphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-(p-cyanophenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-(p-cyanophenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-(p-cyanophenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-(p-cyanophenyl)thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-(p-cyanophenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-(p-cyanophenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-(p-butoxyphenyl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-methylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-ethylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-propylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-butylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-pentylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-trans-4-heptylcyclohexyl-2-[5-(5-propylpyrimidin-2-yl)-thieno[3,2-b]thien-2-yl]-ethane
1-p-ethylphenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-butylphenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-pentylphenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-heptylphenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-cyanophenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-fluorophenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-p-chlorophenyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-4-ethylcyclohexyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-4-propylcyclohexyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-4-butylcyclohexyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane
1-4-pentylcyclohexyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane and
1-4-heptylcyclohexyl-2-[5-pentyl-thieno[2,3-b]thien-2-yl]-ethane.
EXAMPLE 3
A solution of 4.6 g of 3-p-cyanobenzylmercapto-2-formyl-5-(4-pentylcyclohexyl)-thiophene in 25 ml of ethanol is added dropwise, at room temperature and in the course of 5 minutes, to an alcoholate solution prepared from 1.9 g of sodium and 60 ml of ethanol, and the mixture is then boiled for 5 hours. The usual working-up procedure gives 2-p-cyanophenyl-5-(4-pentylcyclohexyl)-thieno[3,2-b]thiophene.
The following compounds are prepared analogously:
2-p-cyanophenyl-5-(4-propylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4-butylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4-heptylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4'-propylcyclohexylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4'-butylcyclohexylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4'-pentylcyclohexylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(4'-heptylcyclohexylcyclohexyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(p-4-propylcyclohexylphenyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(p-4-butylcyclohexylphenyl)-thieno[3,2-b]thiophene,
2-p-cyanophenyl-5-(p-4-pentylcyclohexylphenyl)-thieno[3,2-b]thiophene and
2-p-cyanophenyl-5-(p-4-heptylcyclohexylphenyl)-thieno[3,2-b]thiophene.
EXAMPLE 4
20.5 g of 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylic acid chloride [obtainable by reacting 5-n-heptylthiophene-2-acrylic acid (obtained from 5-n-heptyl-thiophene-2-carbaldehyde and malonic acid in the presence of pyridine/piperidine) with thionyl chloride/pyridine in toluene] are heated to 100° for 4 hours with 13.6 g of 4-n-propylphenol and 8 g of pyridine in 100 ml of toluene. The usual working-up procedure gives 14.8 g of 4-n-propylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate.
The following compounds are prepared analogously:
4-ethylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-butylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-pentylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-heptylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-nonylphenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-cyanophenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-fluorophenyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-ethylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-propylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-butylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-pentylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate,
4-heptylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate and
4-nonylcyclohexyl 5-n-heptyl-3-chlorothieno[3,2-b]thiophene-2-carboxylate.
EXAMPLE 5
20.4 g of 5-n-octylthieno[2,3-b]thiophene-2-carbaldehyde (obtainable from 2-n-octylthieno[2,3-b]thiophene by Vilsmeyer formylation with phosphorus oxychloride/dimethylformamide) and 9.5 g of 2-n-pentylpropane-1,3-diol are dissolved in 150 ml of toluene, a pinch of toluenesulfonic acid is added, and the mixture is heated under a water separator until water is no longer separated off. The acid is washed out with sodium bicarbonate solution, the organic phase is dried over sodium sulfate, and the toluene is distilled off. The pure trans-2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-n-pentyl-1,3-dioxane is obtained by repeated recrystallization from ethanol (17.5 g).
The following compounds are prepared analogously:
2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-ethyl-1,3-dioxane,
2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-propyl-1,3-dioxane,
2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-butyl-1,3-dioxane,
2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-heptyl-1,3-dioxane,
2-(5-n-octylthieno[2,3-b]thien-2-yl)-5-nonyl-1,3-dioxane,
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-ethyl-1,3-dioxane,
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-propyl-1,3-dioxane,
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-butyl-1,3-dioxane,
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-pentyl-1,3-dioxane, M.p. 86°, c.p. 84,5° (monotropic)
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-heptyl-1,3-dioxane,
2-(5-n-pentylthieno[2,3-b]thien-2-yl)-5-nonyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-ethyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-propyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-butyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-pentyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-heptyl-1,3-dioxane,
2-(5-n-propylthieno[2,3-b]thien-2-yl)-5-nonyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-ethyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-propyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-butyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-pentyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-heptyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-nonyl-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-ethylcyclohexyl)-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-propylcyclohexyl)-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-butylcyclohexyl)-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-pentylcyclohexyl)-1,3-dioxane,
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-heptylcyclohexyl)-1,3-dioxane, and
2-(5-cyanothieno[2,3-b]thien-2-yl)-5-(4-nonylcyclohexyl)-1,3-dioxane.
EXAMPLE 6
19 g of 2-[4-(trans-4-n-propylcyclohexyl)-styryl]-5-n-pentylthiophene (obtainable by Friedel Crafts acylation of 2-pentylthiophene with 4-(trans-4-n-propylcyclohexyl)-phenylacetyl chloride and reduction of the resulting ketone with sodium boranate to give the alcohol, followed by dehydration) and 5 g of sulfur are heated to 220° for 3 hours. Subsequent working-up by chromatography gives 8.3 g of 2-[4-trans-4-n-propylcyclohexylphenyl]-5-n-pentylthieno[3,2-b]thiophene.
The following compounds are prepared analogously:
2-[4-(trans-4-ethylcyclohexyl)-phenyl]-5-n-pentylthieno[3,2-b]thiophene,
2-[4-(trans-4-butylcyclohexyl)-phenyl]-5-n-pentylthieno[3,2-b]thiophene,
2-[4-(trans-4-pentylcyclohexyl)-phenyl]-5-n-pentylthieno[3,2-b]thiophene,
2-[4-(trans-4-heptylcyclohexyl)-phenyl]-5-n-pentylthieno[3,2-b]thiophene,
2-[4-(trans-4-nonylcyclohexyl)-phenyl]-5-n-pentylthieno[3,2-b]thiophene,
2-[4-(trans-4-ethylcyclohexyl)-phenyl]-5-n-heptylthieno[3,2-b]thiophene,
2-[4-(trans-4-butylcyclohexyl)-phenyl]-5-n-heptylthieno[3,2-b]thiophene,
2-[4-(trans-4-pentylcyclohexyl)-phenyl]-5-n-heptylthieno[3,2-b]thiophene,
2-[4-(trans-4-heptylcyclohexyl)-phenyl]-5-n-heptylthieno[3,2-b]thiophene,
2-[4-(trans-4-nonylcyclohexyl)-phenyl]-5-n-heptylthieno[3,2-b]thiophene,
2-[4-(trans-4-ethylcyclohexyl)-phenyl]-5-cyanothieno[3,2-b]thiophene,
2-[4-(trans-4-butylcyclohexyl)-phenyl]-5-cyanothieno[3,2-b]thiophene,
2-[4-(trans-4-pentylcyclohexyl)-phenyl]-5-cyanothieno[3,2-b]thiophene,
2-[4-(trans-4-heptylcyclohexyl)-phenyl]-5-cyanothieno[3,2-b]thiophene,
2-[4-(trans-4-nonylcyclohexyl)-phenyl]-5-cyanothieno[3,2-b]thiophene,
2-[trans,trans-4'-ethylcyclohexylcyclohexyl]-5-cyanothieno[3,2-b]thiophene,
2-[trans,trans-4'-butylcyclohexylcyclohexyl]-5-cyanothieno[3,2-b]thiophene,
2-[trans,trans-4'-pentylcyclohexylcyclohexyl]-5-cyanothieno[3,2-b]thiophene
2-[trans,trans-4'-heptylcyclohexylcyclohexyl]-5-cyanothieno[3,2-b]thiophene and
2-[trans,trans-4'-nonylcyclohexylcyclohexyl]-5-cyanothieno[3,2-b]thiophene.
2-(p-ethylphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-propylphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-butylphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-pentylphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-heptylphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-cyanophenyl)-5-propylthieno[3,2-b]thiophene
2-(p-methoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-ethoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-butoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-pentoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-heptoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-nonoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-decoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-undecoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-dodecoxyphenyl)-5-propylthieno[3,2-b]thiophene
2-(p-ethylphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-propylphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-butylphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-pentylphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-heptylphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-cyanophenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-methoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-ethoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-butoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-pentoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-heptoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-nonoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-decoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-undecoxyphenyl)-5-pentylthieno[3,2-b]thiophene
2-(p-dodecoxyphenyl)-5-penthylthieno[3,2-b]thiophene
2-(p-ethylphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-propylphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-butylphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-pentylphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-heptylphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-cyanophenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-methoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-ethoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-butoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-pentoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-heptoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-nonoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-decoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-undecoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(p-dodecoxyphenyl)-5-hexylthieno[3,2-b]thiophene
2-(4'-ethylbiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-propylbiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-butylbiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-pentylbiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-heptylbiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-cyanobiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-methoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-ethoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2(4'-butoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-pentoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-heptoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-nonoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-decoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-undecoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-dodecoxybiphenyl-4-yl)-5-propylthieno[3,2-b]thiophene
2-(4'-ethylbiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-propylbiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-butylbiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-pentylbiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-heptylbiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-cyanobiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-methoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-ethoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-butoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-pentoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-heptoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-nonoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-decoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-undecoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
2-(4'-dodecoxybiphenyl-4-yl)-5-pentylthieno[3,2-b]thiophene
EXAMPLE 7
A mixture of 12 g of 5-n-pentyl-thieno[3,2-b]thiophene-2-carbamidine (obtainable by reacting the nitrile with hydrogen chloride/ethanol and subsequently with ammonia) and 11,4 g of n-pentyl-malonicdialdehyde tetraethylacetal is heated for 12 hours at -160° (bath temperature). The crystals obtained after cooling are purified by chromatography and crystallization.
2-(5-n-pentylthieno[3,2-b]thiophen-2-yl)-5-n-pentyl-primidine is obtained, M.p. 118°, c.p. 106° (monotropic).
The following compounds are prepared analogously:
2-(5-pentylthieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine,
2-(5-pentylthieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine,
2-(5-pentylthieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine,
2-(5-pentylthieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine, M.p. 102°, c.p. 106°,
2-(5-pentylthieno[3,2-b]thiophen-2-yl)-5-nonylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-propylthieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-heptylthieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-cyanothieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-methoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-ethoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-butoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-hexoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-octoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-nonoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-decoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-undecoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-ethylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-propylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-butylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-pentylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-hexylpyrimidine
2-(5-dodecoxythieno[3,2-b]thiophen-2-yl)-5-heptylpyrimidine
EXAMPLE 8
A mixture of 3,5 g of 5-n-pentylthieno[2,3-b]thiophene-2-carboxylic acid chloride [obtainable by reacting 5-n-pentyl-thieno(2,3-b)thiophene-2-carboxylic acid (m.p. 188°, c.p. 187° (monotropic)] with thionyl chloride; the acid is obtainable by reacting ethyl ester of (5-n-pentyl-3-formyl-2-thienylmercapto)acetic acid [obtainable by reacting 2-n-pentylthiophene with butyllithium, sulfur and ethyl ester of chloroacetic acid and followed by Vilsmeyer formylation of the obtained 5-n-pentyl-2-thienylmercapto-acetic ester] with sodium ethylate[ethanol] in 20 ml of toluene was added dropwise to a mixture of 2,25 g of 4-n-pentylphenol, 1,08 g of pyridine and 30 ml of toluene, the mixture is heated to the boil for 2 hours and allowed to cool, the pyridine hydrochloride is filtered off, and the mixture is worked up in the usual manner.
4-n-Pentylphenyl-5-n-pentyl-thieno[2,3-b]thiophene-2-carboxylate of m.p. 51,9° C. and c.p. 90,5° C. is obtained.
The following compounds are prepared analogously:
4-ethylphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propylphenyl 5-pentyl-thieno[2,3-b]hiophene-2-carboxylate,
4-butylphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-heptylphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-ethylphenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propylphenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-butylphenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-pentylphenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-heptylphenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-ethylphenyl 5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propylphenyl 5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-butylphenyl 5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-pentylphenyl 5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-heptylphenyl-5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-ethylphenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propylphenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-butylphenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-pentylphenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-heptylphenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-ethylphenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propylphenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-butylphenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-pentylphenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-heptylphenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-cyanophenyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
4-cyanophenyl 5-butyl-thieno[2,3-b]thiophene-2-carboxylate,
4-cyanophenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate, m.p. 85°, c.p. 129,2°,
4-cyanophenyl 5-hexyl-thieno[2,3-b]thiophene-2-carboxylate,
4-cyanophenyl 5-heptyl-thieno[2,3-b]thiophene-2-carboxylate,
4-cyanophenyl 5-nonyl-thieno[2,3-b]thiophene-2-carboxylate,
4-fluorophenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-chlorophenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-bromophenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-methoxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-ethoxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-propoxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-butoxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-pentyloxyphenyl 5-pentyl-thieno[2,3-]thiophene-2-carboxylate,
4-heptyloxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-nonyloxyphenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4'-propylbiphenylyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4'-cyanobiphenylyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
2'-fluoro-4'-ethylbiphenylyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
2-methyl-4'-propylbiphenylyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-(4-propylcyclohexyl)-phenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
4-(1-cyano-4-propylcyclohexyl)-phenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate and
4-(5-propyl-1,3-dioxan-2-yl)-phenyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate.
trans-4-ethylcyclohexyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-propylcyclohexyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate, M.p. 60°, c.p. 91°
trans-4-butylcyclohexyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-pentylcyclohexyl 5-pentyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-heptylcyclohexyl 5-pentyl-thieno[2,3-b]-thiophene-2-carboxylate,
trans-4-ethylcyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-propylcyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-butylcyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-pentylcyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-heptylcyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-ethoxycyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans-4-butoxycyclohexyl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate,
trans,trans-4-ethylbicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-propylbicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-butylbicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-pentylbicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-heptylbicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-ethoxybicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-butoxybicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
trans,trans-4-propionyloxybicyclohex-4'-yl 5-propyl-thieno[2,3-b]thiophene-2-carboxylate
Examples of liquid crystalline phases according to the invention which contain at least one compound of the formula I are given below:
EXAMPLE A
A liquid crystalline phase consisting of
15% of p-trans-4-ethylcyclohexylbenzonitrile,
15% of p-trans-4-butylcyclohexylbenzonitrile,
10% of 4-ethyl-4'-cyanobiphenyl,
13% of 4-butyl-4'-cyanobiphenyl,
11% of 4-cyano-4'-(trans-4-pentylcyclohexyl)-biphenyl,
6% of 4-p-cyanophenyl-4'-pentylbiphenyl,
15% of 4-pentylphenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate and
15% of 4-propylphenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of -8°, a clear point of 67° and a viscosity of 29 cSt.
EXAMPLE B
A liquid crystalline phase consisting of
8% of 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
9% of 2-p-cyanophenyl-5-propyl-1,3-dioxane,
4% of p-cyanophenyl p-ethylbenzoate,
3% of p-cyanophenyl p-propylbenzoate,
11% of p-trans-4-ethylcyclohexylbenzonitrile,
13% of p-trans-4-butylcyclohexylbenzonitrile,
8% of 4-ethyl-4'-cyanobiphenyl,
12% of 4-butyl-4'-cyanobiphenyl,
5% of p-cyanophenyl p-trans-4-pentylcyclohexylbenzoate,
9% of 4-cyanophenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate,
9% of 4-cyanophenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate and
9% of 4-cyanophenyl 5-heptylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of -11°, a clear point of 61° and a viscosity of 36 cSt. An electro-optical display element containing this phase as a dielectric has a low threshold voltage V10 of 1.15 V.
EXAMPLE C
A liquid crystalline phase consisting of
10% of 2-p-cyanophenyl-5-ethyl-1,3-dioxane,
10% of 2-p-cyanophenyl-5-propyl-1,3-dioxane,
16% of 2-p-cyanophenyl-5-butyl-1,3-dioxane,
10% of 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
18% of 4-propylphenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate,
18% of 4-pentylphenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate and
18% of 4-heptylphenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of -10°, a clear point of 62° and a viscosity of 31 cSt.
EXAMPLE D
A liquid crystalline phase consisting of
4% of 2-p-cyanophenyl-5-propyl-1,3-dioxane,
5% of 2-p-cyanophenyl-5-butyl-1,3-dioxane,
4% of 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
10% of p-methoxyphenyl trans-4-propylcyclohexanecarboxylate,
11% of p-ethoxyphenyl trans-4-propylcyclohexanecarboxylate,
15% of p-methoxyphenyl trans-4-butylcyclohexanecarboxylate,
10% of p-ethoxyphenyl trans-4-butylcyclohexanecarboxylate,
10% of p-methoxyphenyl trans-4-pentylcyclohexanecarboxylate,
13% of p-pentylphenyl trans-4-pentylcyclohexanecarboxylate,
6% of 4-cyanophenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate,
7% of 4-cyanophenyl 5-pentylthieno[3,2-]thiophene-2-carboxylate and
5% of 4-cyanophenyl 5-heptylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of -12°, a clear point of 71° and a viscosity of 18 cSt. In an electro-optical display element, this dielectric has good multiplex properties (1:32).
EXAMPLE E
A liquid crystalline phase consisting of
18.0% of p-trans-4-propylcyclohexylbenzonitrile,
13.5% of p-trans-4-butylcyclohexylbenonitrile,
24.5% of p-trans-4-pentylcyclohexylbenonitrile,
15.5% of p-trans-4-heptylcyclohexylbenonitrile,
7.0% of 4-cyano-4'-(trans-4-pentylcyclohexyl)-biphenyl,
7.0% of 4-(trans-4-pentylcyclohexyl)-4'-(trans-4-propylcyclohexyl)-biphenyl,
6.0% of 4-p-cyanophenyl-4'-pentyl-biphenyl,
8.0% of p-trans-propylcyclohexylphenyl trans-4-butylcyclohexanecarboxylate and
0.5% of 4-cyanophenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of -14° and a clear point of 88°.
EXAMPLE F
A liquid crystalline phase consisting of
14% of p-trans-4-propylcyclohexylbenzonitrile,
16% of 2-p-cyanophenyl-5-butyl-1,3-dioxane,
10% of 2-p-cyanophenyl-5-pentyl-1,3-dioxane,
14% of 4-cyanophenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate,
10% of 4-cyanophenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate,
8% of 4-cyanophenyl 5-heptylthieno[3,2-b]thiophene-2-carboxylate,
16% of 4-propylphenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate and
12% of 4-pentylphenyl 5-pentylthieno[3,2-b]thiophene-2-carboxylate
is a good host material for pleochroic dyes.
EXAMPLE G
A liquid crystalline phase consisting of
66.6% of p-pentylphenyl p-methoxybenzoate,
33.3% of p-pentylphenyl p-hexyloxybenzoate and
0.1% of 4-propylphenyl 5-propylthieno[3,2-b]thiophene-2-carboxylate
has a melting point of 13°.
The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Claims (18)

What is claimed is:
1. A liquid crystalline phase comprising at least two liquid-crystal components, wherein at least one component is of the formula
R.sup.1 --(A.sup.1).sub.m --Z.sup.1 --A--(Z.sup.2 --A.sup.2).sub.n --R.sup.2
wherein
R1 and R2 are independently each H, alkyl of 1-12 C-atoms, or alkyl of 1-12 C-atoms, in which one or two non-adjacent CH2 groups are replaced by an oxa atom, --CO-- or --CH═CH--, in each case the resultant groups having 1-12 C-- and oxa atoms in total, or independently are each F, Cl, Br, CN, --COOR or --O--COR;
A1 and A2 are independently each 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, tetrahydropyran-2,5-diyl, pyridazine-3,6-diyl or the corresponding N-oxide, piperidine-1,4-diyl, 1,4-bicyclo[2.2.2]octylene or pyrimidine-2,5-diyl each of which is unsubstituted or substituted by one or two of F, Cl, Br, CN or CH3 ;
A is a group of the formula 1 or 2 ##STR6## each of which is unsubstituted or substituted by one or two Cl or Br atoms;
Z1 and Z2 are independently each --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O-- or a single bond;
R is alkyl of 1-10 C-atoms;
m is 1 or 2;
n is 0 or 1; and
when m is 2, the two groups A1 are identical or different.
2. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --A.sup.1 --Z.sup.1 --A--R.sup.2.
3. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --A.sup.1 --Z.sup.1 --A--Z.sup.2 --A.sup.2 --R.sup.2.
4. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --(A.sup.1).sub.2 --Z.sup.1 --A--R.sup.2.
5. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --(A.sup.1).sub.2 --Z.sup.1 --A--Z.sup.2 --A.sup.2 --R.sup.2.
6. A liquid crystalline phase of claim 2 wherein at least one compound is of the formula
R.sup.1 --Phe--Z.sup.1 --A--R.sup.2
R.sup.1 --Cy--Z.sup.1 --A--R.sup.2
R.sup.1 --Dio--Z.sup.1 --A--R.sup.2
R.sup.1 --Pip--Z.sup.1 --A--R.sup.2
R.sup.1 --Bic--Z.sup.1 --A--R.sup.2 or
R.sup.1 --Pyr--Z.sup.1 --A--R.sup.2
wherein Phe is 1,4-phenylene, Cy is 1,4-cyclohexylene, Dio is 1,3-dioxane-2,5-diyl, Bi is bicyclo[2.2.2.]octylene, Pip is piperidine-1,4-diyl and Pyr is pyrimidine-2,5-diyl.
7. A liquid crystalline phase of claim 6 wherein at least one compound is of the formula
R.sup.1 --Phe--Z.sup.1 --A--R.sup.2
R.sup.1 --Cy--Z.sup.1 --A--R.sup.2 or
R.sup.1 --Dio--Z.sup.1 --A--R.sup.2
8. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2
R.sup.1 --Dio--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
R.sup.1 --Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2
R.sup.1 --Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
R.sup.1 --Phe--Phe--Z.sup.1 --A--R.sup.2
R.sup.1 --Phe--Cy--Z.sup.1 --A--R.sup.2
R.sup.1 --Cy--Phe--Z.sup.1 --A--R.sup.2
R.sup.1 --Cy--Cy--Z.sup.1 --A--R.sup.2
R.sup.1 --Phe--Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2
R.sup.1 --Phe--Phe--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
R.sup.1 --Phe--Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2
R.sup.1 --Phe--Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
R.sup.1 --Cy--Phe--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2
R.sup.1 --Cy--Phe--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
R.sup.1 --Cy--Cy--Z.sup.1 --A--Z.sup.2 --Phe--R.sup.2 or
R.sup.1 --Cy--Cy--Z.sup.1 --A--Z.sup.2 --Cy--R.sup.2
wherein Phe is 1,4-phenylene, Cy is 1,4-cyclohexylene and Dio is a 1,3-dioxane-2,5-diyl group.
9. A liquid crystalline phase of claim 1 wherein at least one compound is of the formula
R.sup.1 --Phe--A--R.sup.2
R.sup.1 --Phe--CO--O--A--R.sup.2
R.sup.1 --Phe--O--CO--A--R.sup.2
R.sup.1 --Phe--CH.sub.2 CH.sub.2 --A--R.sup.2
R.sup.1 --Phe--O--CH.sub.2 --A--R.sup.2
R.sup.1 --Phe--CH.sub.2 --O--A--R.sup.2
R.sup.1 --Cy--A--R.sup.2
R.sup.1 --Cy--CO--O--A--R.sup.2
R.sup.1 --Cy--O--CO--A--R.sup.2
R.sup.1 --Cy--CH.sub.2 CH.sub.2 --A--R.sup.2
R.sup.1 --Cy--O--CH.sub.2 --A--R.sup.2
R.sup.1 --Cy--CH.sub.2 --O--A--R.sup.2
R.sup.1 --Dio--A--R.sup.2
R.sup.1 --Pip--A--R.sup.2
R.sup.1 --Bic--A--R.sup.2
R.sup.1 --Pyr--A--R.sup.2 or
R.sup.1 --Phe--Phe--A--R.sup.2
wherein Phe is 1,4-phenylene, Cy is 1,4-cyclohexylene, Dio is 1,3-dioxane-2,5-diyl, Bi is bicyclo[2.2.2.]octylene, Pip is piperidine-1,4-diyl and Pyr is pyrimidine-2,5-diyl.
10. A liquid crystalline phase of claim 1 wherein R1 and R2 are each alkyl or oxaalkyl.
11. A liquid crystalline phase of claim 1 wherein A1 and A2 are b 1,4-cyclohexylene, 1,4-phenylene, or pyrimidine-2,5-diyl.
12. A liquid crystalline phase of claim 1 wherein one of Z1 and Z2 is a single bond and the other is --O--CO--, --CO--O-- or --CH2 CH2 --.
13. In a liquid crystalline phase comprising at least two liquid-crystal components, wherein at least one is a compound having the structure
ti wing group-ring-(bridging element-ring).sub.(1-3) -wing group
wherein the ring groups, the bridging elements and at least one ring are conventional structural elements in liquid crystal compounds, the improvement wherein one ring is of the formula ##STR7## and said at least one compound is present in an amount effective to improve the elastic properties of the phase.
14. In a liquid crystal display element comprising a liquid crystalline phase, the improvement wherein the phase is one of claim 1.
15. In an electro-optical display element, comprising a liquid crystalline dielectric, the improvement wherein the latter is a liquid crystalline phase of claim 1.
16. In an electro-optical display element, comprising a liquid crystalline dielectric, the improvement wherein the latter is a liquid crystalline phase of claim 13.
17. A liquid crystalline phase of claim 1, wherein R1 and R2 are independently each alkyl of 1-12 C-atoms, or alkyl of 1-12 C-atoms, in which one or two non-adjacent CH2 groups are replaced by an oxa atom, --CO-- or --CH═CH--, in each case the resultant groups having 1-12 C-- and oxa atoms in total, or independently are each F, Cl, Br, CN, --COOR or --O--COR.
18. A liquid crystalline phase of claim 1, wherein A1 and A2 are each independently 1,4-phenylene or 1,4-cyclohexylene, each unsubstituted or substituted by one F or CN group; Z1 is --CO--O--, --O--CO--, --CH2 CH2 -- or a single bond; and Z2 is a single bond.
US06/674,891 1983-11-25 1984-11-26 Thienothiophene derivatives Expired - Fee Related US4639328A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833342631 DE3342631A1 (en) 1983-11-25 1983-11-25 THIENOTHIOPHENE DERIVATIVES
DE3342631 1983-11-25

Publications (1)

Publication Number Publication Date
US4639328A true US4639328A (en) 1987-01-27

Family

ID=6215231

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/674,891 Expired - Fee Related US4639328A (en) 1983-11-25 1984-11-26 Thienothiophene derivatives

Country Status (6)

Country Link
US (1) US4639328A (en)
EP (1) EP0144013B1 (en)
JP (1) JPS60136583A (en)
AT (1) ATE40137T1 (en)
DD (1) DD229146A5 (en)
DE (2) DE3342631A1 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853149A (en) * 1986-10-25 1989-08-01 Merck Patent Gesellschaft Mit Beschrankter Haftung Heterocyclic liquid crystal compounds
EP0392510A1 (en) * 1989-04-14 1990-10-17 Canon Kabushiki Kaisha Mesomorphic compound, liquid crystal composition and liquid crystal device using same
US5432286A (en) * 1992-10-10 1995-07-11 Hoechst Aktiengesellschaft Substituted thieno[3,2-b]thiophenes and their use
WO1999012989A1 (en) * 1997-09-05 1999-03-18 Cambridge Display Technology Ltd. Compounds for electronic devices
US6818260B2 (en) 2001-07-09 2004-11-16 Merck Patent Gmbh Thienothiophene derivatives
US20050090640A1 (en) * 2003-08-28 2005-04-28 Martin Heeney Mono-, oligo-and polythieno[2,3-b]thiophenes
US20050151122A1 (en) * 2004-01-12 2005-07-14 Xuezhong Jiang Dispersions and films comprising conducting polymer for optoelectronic devices
US20050209419A1 (en) * 2002-07-11 2005-09-22 Steffen Zahn Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
KR100560776B1 (en) * 2000-10-06 2006-03-13 삼성에스디아이 주식회사 Compound for hole transport and organic electroluminescent device using same
US20060071200A1 (en) * 2004-10-04 2006-04-06 Nordquist Andrew F Substituted thienothiophene monomers and conducting polymers
US20060074250A1 (en) * 2004-10-04 2006-04-06 Steffen Zahn Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20060071199A1 (en) * 2004-10-04 2006-04-06 Steffen Zahn Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20060223977A1 (en) * 2002-07-11 2006-10-05 Steffen Zahn Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
US20070008603A1 (en) * 2005-07-11 2007-01-11 Sotzing Gregory A Electrochromic devices utilizing very low band gap conjugated counter electrodes: preparation and use
US20070014939A1 (en) * 2005-07-14 2007-01-18 Russell Gaudiana Polymers with low band gaps and high charge mobility
US20070020526A1 (en) * 2005-07-14 2007-01-25 Russell Gaudiana Polymers with low band gaps and high charge mobility
US20070089845A1 (en) * 2005-01-31 2007-04-26 Sotzing Gregory A Conjugated polymer fiber, preparation and use thereof
US20070181179A1 (en) * 2005-12-21 2007-08-09 Konarka Technologies, Inc. Tandem photovoltaic cells
US20070191576A1 (en) * 2006-02-16 2007-08-16 Sotzing Gregory A Conductive polymers from precursor polymers, method of making, and use thereof
US20070246094A1 (en) * 2005-07-14 2007-10-25 Konarka Technologies, Inc. Tandem photovoltaic cells
US20070267055A1 (en) * 2005-07-14 2007-11-22 Konarka Technologies, Inc. Tandem Photovoltaic Cells
US20080006324A1 (en) * 2005-07-14 2008-01-10 Konarka Technologies, Inc. Tandem Photovoltaic Cells
US7332223B2 (en) 2002-07-11 2008-02-19 University Of Connecticut Polymers comprising thieno [3,4-b]thiophene and methods of making and using the same
US20080087324A1 (en) * 2006-10-11 2008-04-17 Konarka Technologies, Inc. Photovoltaic Cell With Silole-Containing Polymer
US20080121281A1 (en) * 2006-10-11 2008-05-29 Konarka Technologies, Inc. Photovoltaic Cell With Thiazole-Containing Polymer
US20090072200A1 (en) * 2004-08-21 2009-03-19 Martin Heeney MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE
WO2009051390A3 (en) * 2007-10-15 2009-07-16 Dongjin Semichem Co Ltd Novel thiophene-based dye and preparation thereof
US20090211633A1 (en) * 2008-02-21 2009-08-27 Konarka Technologies Inc. Tandem Photovoltaic Cells
US20090326187A1 (en) * 2008-06-26 2009-12-31 Sotzing Gregory A SYNTHESIS OF THIENO[3,4-b]THIOPHENE, THIENO[3,4-b]FURAN, RELATED COMPOUNDS AND THEIR DERIVATIVES AND USE THEREOF
US20100032018A1 (en) * 2008-08-07 2010-02-11 Konarka Technologies, Inc. Novel Photoactive Polymers
US20100113727A1 (en) * 2005-07-11 2010-05-06 Sotzing Gregory A Polymers of thieno[3,4-b]furan, method of making, and use thereof
US20140319428A1 (en) * 2011-07-27 2014-10-30 Merck Patent Gmbh Small molecules and their use as organic semiconductors
CN112979676A (en) * 2019-12-12 2021-06-18 Dic株式会社 Compound, composition, liquid crystal composition and high-frequency phase shifter
CN114717010A (en) * 2022-04-29 2022-07-08 苏州汉朗光电有限公司 Bithiophene high-refractive-index liquid crystal composition and application thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346175A1 (en) * 1983-12-21 1985-07-11 Merck Patent Gmbh, 6100 Darmstadt PYRIDYLTHIOPHENE
DE59707350D1 (en) * 1996-04-04 2002-07-04 Rolic Ag Zug Imidazothiazole derivatives as a component of liquid-crystalline mixtures
KR100911136B1 (en) * 2001-07-09 2009-08-06 메르크 파텐트 게엠베하 Reactive thienothiophenes
CN113195501A (en) 2018-12-13 2021-07-30 默克专利股份有限公司 Liquid-crystalline medium
WO2021079743A1 (en) * 2019-10-21 2021-04-29 Dic株式会社 Compound, liquid crystal composition and high-frequency phase shifter

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU157980A1 (en) *
US3189618A (en) * 1961-08-31 1965-06-15 Du Pont Thiophthenes
US4124596A (en) * 1976-01-29 1978-11-07 Rhone-Poulenc Industries Thienothienylcarbonyl-phenylalkanoic acids and derivatives thereof
JPS55151077A (en) * 1979-05-14 1980-11-25 Hitachi Ltd Nematic liquid crystal composition
US4510069A (en) * 1982-08-26 1985-04-09 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclohexane derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU157980A1 (en) *
US3189618A (en) * 1961-08-31 1965-06-15 Du Pont Thiophthenes
US4124596A (en) * 1976-01-29 1978-11-07 Rhone-Poulenc Industries Thienothienylcarbonyl-phenylalkanoic acids and derivatives thereof
JPS55151077A (en) * 1979-05-14 1980-11-25 Hitachi Ltd Nematic liquid crystal composition
US4510069A (en) * 1982-08-26 1985-04-09 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclohexane derivatives

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Behringer, H., et al., Liebigs Annalen Chemie, vol. 10, pp. 1729 1750 (1981). *
Behringer, H., et al., Liebigs Annalen Chemie, vol. 10, pp. 1729-1750 (1981).
Karamysheva, L. A., et al., Mol. Cryst. Liq. Cryst., vol. 67, pp. 241 252 (1981). *
Karamysheva, L. A., et al., Mol. Cryst. Liq. Cryst., vol. 67, pp. 241-252 (1981).
Nash, J. A., et al., Mol. Cryst. Liq. Cryst., vol. 25, pp. 299 321 (1974). *
Nash, J. A., et al., Mol. Cryst. Liq. Cryst., vol. 25, pp. 299-321 (1974).
Osman, M. A., et al., Mol. Cryst. Liq. Cryst., vol. 82 (Letters), pp. 339 344 (Jan. 1983). *
Osman, M. A., et al., Mol. Cryst. Liq. Cryst., vol. 82 (Letters), pp. 339-344 (Jan. 1983).
Pavluchenko, A. I., et al., Advances in Liquid Crystal Research & Applications, Bata, L., Ed., Pergamon Press, Oxford, pp. 1007 1013 (1980). *
Pavluchenko, A. I., et al., Advances in Liquid Crystal Research & Applications, Bata, L., Ed., Pergamon Press, Oxford, pp. 1007-1013 (1980).

Cited By (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853149A (en) * 1986-10-25 1989-08-01 Merck Patent Gesellschaft Mit Beschrankter Haftung Heterocyclic liquid crystal compounds
EP0392510A1 (en) * 1989-04-14 1990-10-17 Canon Kabushiki Kaisha Mesomorphic compound, liquid crystal composition and liquid crystal device using same
US5118441A (en) * 1989-04-14 1992-06-02 Canon Kabushiki Kaisha Mesomorphic compound, liquid crystal composition and liquid crystal device using same
US5432286A (en) * 1992-10-10 1995-07-11 Hoechst Aktiengesellschaft Substituted thieno[3,2-b]thiophenes and their use
US5684165A (en) * 1992-10-10 1997-11-04 Hoechst Aktiengesellschaft Substituted thieno 3,2b!thiophenes and their use
US6626566B2 (en) 1997-09-05 2003-09-30 Cambridge Display Technology Limited Compounds for electronic devices
US6403809B1 (en) 1997-09-05 2002-06-11 Cambridge Display Technolog Limited Compounds for electronic devices
JP3313357B2 (en) 1997-09-05 2002-08-12 ケンブリッジ ディスプレイ テクノロジー リミテッド Compounds for electronic devices
WO1999012989A1 (en) * 1997-09-05 1999-03-18 Cambridge Display Technology Ltd. Compounds for electronic devices
KR100560776B1 (en) * 2000-10-06 2006-03-13 삼성에스디아이 주식회사 Compound for hole transport and organic electroluminescent device using same
US6818260B2 (en) 2001-07-09 2004-11-16 Merck Patent Gmbh Thienothiophene derivatives
US7432340B2 (en) 2002-07-11 2008-10-07 Air Products And Chemicals, Inc. Fluorinated alkyl substituted-thieno[3,4-]thiophene monomers and polymers therefrom
US20050209419A1 (en) * 2002-07-11 2005-09-22 Steffen Zahn Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
US20060223977A1 (en) * 2002-07-11 2006-10-05 Steffen Zahn Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
US7332223B2 (en) 2002-07-11 2008-02-19 University Of Connecticut Polymers comprising thieno [3,4-b]thiophene and methods of making and using the same
US7572879B2 (en) 2002-07-11 2009-08-11 Air Products And Chemicals, Inc. Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
US20050090640A1 (en) * 2003-08-28 2005-04-28 Martin Heeney Mono-, oligo-and polythieno[2,3-b]thiophenes
US7183418B2 (en) 2003-08-28 2007-02-27 Merck Patent Gesellschaft Mono-, oligo- and polythieno[2,3-b]thiophenes
EP1559739A1 (en) * 2004-01-12 2005-08-03 Air Products And Chemicals, Inc. Dispersions and films comprising conducting polymer for optoelectronic devices
US8920678B2 (en) 2004-01-12 2014-12-30 Samsung Electronics Co., Ltd. Dispersions and films comprising conducting polymer for optoelectronic devices
US20050151122A1 (en) * 2004-01-12 2005-07-14 Xuezhong Jiang Dispersions and films comprising conducting polymer for optoelectronic devices
US7270871B2 (en) 2004-01-12 2007-09-18 Air Products And Chemicals, Inc. Dispersions and films comprising conducting polymer for optoelectronic devices
KR100718035B1 (en) * 2004-01-12 2007-05-16 에어 프로덕츠 앤드 케미칼스, 인코오포레이티드 Dispersions and films comprising conducting polymer for optoelectronic devices
US20090072200A1 (en) * 2004-08-21 2009-03-19 Martin Heeney MONOMERS, OLIGOMERS AND POLYMERS OF THIENO[2,3-b]THIOPHENE
US8114316B2 (en) 2004-08-21 2012-02-14 Merck Patent Gmbh Monomers, oligomers and polymers of thieno[2,3-b]thiophene
CN100355757C (en) * 2004-10-04 2007-12-19 气体产品与化学公司 Substituted thienothiophene monomers and conducting polymers
US7118692B2 (en) 2004-10-04 2006-10-10 Air Products And Chemicals, Inc. Substituted thienothiophene monomers and conducting polymers
US20060071200A1 (en) * 2004-10-04 2006-04-06 Nordquist Andrew F Substituted thienothiophene monomers and conducting polymers
US7241904B2 (en) 2004-10-04 2007-07-10 Air Products And Chemicals, Inc. Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20060074250A1 (en) * 2004-10-04 2006-04-06 Steffen Zahn Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20060071199A1 (en) * 2004-10-04 2006-04-06 Steffen Zahn Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US7060846B2 (en) 2004-10-04 2006-06-13 Air Products And Chemicals, Inc. Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US7094365B2 (en) 2004-10-04 2006-08-22 Air Products And Chemicals, Inc. Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20060208233A1 (en) * 2004-10-04 2006-09-21 Steffen Zahn Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
US20070089845A1 (en) * 2005-01-31 2007-04-26 Sotzing Gregory A Conjugated polymer fiber, preparation and use thereof
US8178629B2 (en) 2005-01-31 2012-05-15 University Of Connecticut Conjugated polymer fiber, preparation and use thereof
US7737247B2 (en) 2005-07-11 2010-06-15 The University Of Connecticut Polymers of thieno[3,4-b]furan, method of making, and use thereof
US20070008603A1 (en) * 2005-07-11 2007-01-11 Sotzing Gregory A Electrochromic devices utilizing very low band gap conjugated counter electrodes: preparation and use
US7746533B2 (en) 2005-07-11 2010-06-29 The University Of Connecticut Electrochromic devices utilizing very low band gap conjugated counter electrodes: preparation and use
US20100113727A1 (en) * 2005-07-11 2010-05-06 Sotzing Gregory A Polymers of thieno[3,4-b]furan, method of making, and use thereof
US20070014939A1 (en) * 2005-07-14 2007-01-18 Russell Gaudiana Polymers with low band gaps and high charge mobility
US7772485B2 (en) 2005-07-14 2010-08-10 Konarka Technologies, Inc. Polymers with low band gaps and high charge mobility
US20070020526A1 (en) * 2005-07-14 2007-01-25 Russell Gaudiana Polymers with low band gaps and high charge mobility
US20070158620A1 (en) * 2005-07-14 2007-07-12 Russell Gaudiana Polymers with low band gaps and high charge mobility
US7781673B2 (en) * 2005-07-14 2010-08-24 Konarka Technologies, Inc. Polymers with low band gaps and high charge mobility
US8058550B2 (en) 2005-07-14 2011-11-15 Konarka Technologies, Inc. Polymers with low band gaps and high charge mobility
US20100180944A1 (en) * 2005-07-14 2010-07-22 Konarka Technologies, Inc. Polymers with low band gaps and high charge mobility
US20070267055A1 (en) * 2005-07-14 2007-11-22 Konarka Technologies, Inc. Tandem Photovoltaic Cells
US8158881B2 (en) 2005-07-14 2012-04-17 Konarka Technologies, Inc. Tandem photovoltaic cells
US20070246094A1 (en) * 2005-07-14 2007-10-25 Konarka Technologies, Inc. Tandem photovoltaic cells
US20070017571A1 (en) * 2005-07-14 2007-01-25 Russell Gaudiana Polymers with low band gaps and high charge mobility
US20080006324A1 (en) * 2005-07-14 2008-01-10 Konarka Technologies, Inc. Tandem Photovoltaic Cells
US8975512B2 (en) 2005-12-21 2015-03-10 Merck Patent Gmbh Tandem photovoltaic cells
US20070181179A1 (en) * 2005-12-21 2007-08-09 Konarka Technologies, Inc. Tandem photovoltaic cells
US20070191576A1 (en) * 2006-02-16 2007-08-16 Sotzing Gregory A Conductive polymers from precursor polymers, method of making, and use thereof
US9127121B2 (en) 2006-02-16 2015-09-08 The University Of Connecticut Conductive polymers from precursor polymers, method of making, and use thereof
US8227567B2 (en) 2006-02-16 2012-07-24 University Of Connecticut Conductive polymers from precursor polymers, method of making, and use thereof
US8008421B2 (en) 2006-10-11 2011-08-30 Konarka Technologies, Inc. Photovoltaic cell with silole-containing polymer
US20080121281A1 (en) * 2006-10-11 2008-05-29 Konarka Technologies, Inc. Photovoltaic Cell With Thiazole-Containing Polymer
US8008424B2 (en) 2006-10-11 2011-08-30 Konarka Technologies, Inc. Photovoltaic cell with thiazole-containing polymer
US9123895B2 (en) 2006-10-11 2015-09-01 Merck Patent Gmbh Photovoltaic cell with thiazole-containing polymer
US8563678B2 (en) 2006-10-11 2013-10-22 Merck Patent Gmbh Photovoltaic cell with thiazole-containing polymer
US20080087324A1 (en) * 2006-10-11 2008-04-17 Konarka Technologies, Inc. Photovoltaic Cell With Silole-Containing Polymer
US8962783B2 (en) 2006-10-11 2015-02-24 Merck Patent Gmbh Photovoltaic cell with silole-containing polymer
CN103254659B (en) * 2007-10-15 2015-11-18 株式会社东进世美肯 Thiophene series dye and its preparation method
WO2009051390A3 (en) * 2007-10-15 2009-07-16 Dongjin Semichem Co Ltd Novel thiophene-based dye and preparation thereof
CN103254658A (en) * 2007-10-15 2013-08-21 株式会社东进世美肯 Thiophene series dye and its preparation method
CN103254659A (en) * 2007-10-15 2013-08-21 株式会社东进世美肯 Thiophene series dye and its preparation method
CN103254658B (en) * 2007-10-15 2015-03-11 株式会社东进世美肯 Thiophene dye and preparation method thereof
US20090211633A1 (en) * 2008-02-21 2009-08-27 Konarka Technologies Inc. Tandem Photovoltaic Cells
US20090326187A1 (en) * 2008-06-26 2009-12-31 Sotzing Gregory A SYNTHESIS OF THIENO[3,4-b]THIOPHENE, THIENO[3,4-b]FURAN, RELATED COMPOUNDS AND THEIR DERIVATIVES AND USE THEREOF
US8168671B2 (en) 2008-06-26 2012-05-01 The University Of Connecticut Synthesis of thieno[3,4-b]thiophene, thieno[3,4-b]furan, related compounds and their derivatives and use thereof
US8455606B2 (en) 2008-08-07 2013-06-04 Merck Patent Gmbh Photoactive polymers
US20100032018A1 (en) * 2008-08-07 2010-02-11 Konarka Technologies, Inc. Novel Photoactive Polymers
US20140319428A1 (en) * 2011-07-27 2014-10-30 Merck Patent Gmbh Small molecules and their use as organic semiconductors
CN112979676A (en) * 2019-12-12 2021-06-18 Dic株式会社 Compound, composition, liquid crystal composition and high-frequency phase shifter
CN114717010A (en) * 2022-04-29 2022-07-08 苏州汉朗光电有限公司 Bithiophene high-refractive-index liquid crystal composition and application thereof

Also Published As

Publication number Publication date
EP0144013A2 (en) 1985-06-12
JPS60136583A (en) 1985-07-20
DE3342631A1 (en) 1985-06-05
DE3476207D1 (en) 1989-02-23
EP0144013B1 (en) 1989-01-18
DD229146A5 (en) 1985-10-30
EP0144013A3 (en) 1986-04-09
ATE40137T1 (en) 1989-02-15

Similar Documents

Publication Publication Date Title
US4639328A (en) Thienothiophene derivatives
US4726911A (en) Heterocyclic compounds
US4704227A (en) Liquid crystal compounds
US4818431A (en) Liquid crystal dielectric
US4882082A (en) Nitrogen-containing hetercyclic compounds
US4713197A (en) Nitrogen-containing heterocyclic compounds
US4510069A (en) Cyclohexane derivatives
US4659502A (en) Ethane derivatives
US5064569A (en) Optically active compounds
US4846998A (en) Cyclohexane derivatives
US5043093A (en) Pyrimidines
US4724097A (en) Bicyclohexylethanes
US4943384A (en) Cyclohexane derivatives
JP2632401B2 (en) Substituted phenyl trifluoromethyl ether compounds
US5055223A (en) Aryl-sulfur pentafluorides
US4873019A (en) Cyclopentane derivatives
US4462923A (en) Disubstituted pyrimidines
US4913837A (en) Heterocyclic compounds
US5308537A (en) Mesogenic compounds
US5324449A (en) Substituted phenyl trifluoromethyl ethers
US4986931A (en) Cyclohexane derivatives
US4755323A (en) Liquid-crystalline dielectrics
DD261803A5 (en) CHIRAL-TREATED SMEKTIC LIQUID CRYSTALLINE PHASE
US5254698A (en) Phenyldioxanes
US4659503A (en) Pyridylthiophenes

Legal Events

Date Code Title Description
AS Assignment

Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:KRAUSE, JOACHIM;ROMER, MICHAEL;WEBER, GEORG;REEL/FRAME:004589/0435

Effective date: 19841109

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19950202

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362